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SUMMARY 
 
Polo-like kinase 4 (Plk4), also known as Snk/Fnk-akin kinase (Sak), is the most 
structurally divergent member of the Polo-like kinase family (Fode et al., 1994; Leung 
et al., 2002) and has been associated with cell proliferation (Fode et al., 1994).   Most 
importantly, Plk4-/- mice were found to be embryonically lethal whereas heterozygous 
Plk+/- mice exhibited an increased incidence of tumorigenesis (Hudson et al., 2001; 
Ko et al., 2005).  However, very little data has been reported on the function of human 
Plk4.  
Here, we embarked on a functional characterisation of human Plk4 in cultured 
cells.  This kinase localised to the centrosome throughout the cell cycle, and 
overexpression studies revealed that an excess of wild type Plk4 induced the 
overduplication of centrioles in cells.  This process was dependent on the cyclin-
dependent kinase (Cdk) 2 in addition to CP110 and human Sas-6, two proteins shown 
to be involved in centriole duplication (Chen et al., 2002b; Leidel et al., 2005).  
Conversely, depletion of endogenous Plk4 resulted in an inhibition of centriole 
duplication leading to a loss of centrioles from dividing cells.  These data from gain-
of-function and loss-of-function experiments demonstrated that Plk4 is an essential 
regulator of centriole duplication.   
Further microscopic studies revealed that excess Plk4 activity resulted in the 
formation of rosette-like structures around centrioles.  These structures recruited 
CPAP which is the human homologue of Sas-4, a protein required for centriole 
duplication in the nematode worm (Caenorhabditis elegans).  We propose that these 
structures represent centriole precursors. 
The study presented here is a starting point for further work.  The identification 
of Plk4 as a central regulator of centriole duplication will allow the characterisation of 
upstream and downstream regulatory pathways, whereas a continued search for 
interaction partners should resolve the function of this kinase.  In particular, the 
analysis of rosette-like centriole precursors is a promising avenue to provide insights 
into the mechanism of centriole duplication.  
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INTRODUCTION 
 
Since Boveri’s discovery of the centrosome more than a century ago, this cellular 
organelle has fascinated biologists with its intriguing and complex nature.  One 
particular aspect that has recently garnered much attention is the centrosome’s 
unusual duplication cycle, reminiscent in many respects to that of DNA.  The 
interphase centriole must duplicate exactly once per cell cycle and this must be 
completed before mitosis.  Furthermore, the regulation of this event involves several 
proteins, some located at the centrosome, others involved in mitotic processes not 
restricted to this organelle.  At present it is clear that not all components and 
regulatory mechanisms of centriole duplication have been fully characterised.   
Never-the-less, deregulation of centriole duplication is known to result in cells 
with multiple centrosomes and the formation of multipolar spindles, leading to 
chromosome instability (Brinkley, 2001; Nigg E.A., 2004; Goepfert and Brinkley, 
2004).  In fact, cells from several tumours are known to exhibit excess numbers of 
centrosomes (Lingle et al., 1998; Pihan et al., 1998; Carroll et al., 1999), and this 
situation cannot be remedied by the cell due to a lack of a specific checkpoint for 
multipolar spindles (Sluder et al., 1997).  Centrosome duplication must therefore be 
tightly coordinated with other events during the cell cycle.  Here, the basic structure 
and function of the centrosome will be presented, followed by a review of proteins 
involved in centrosome duplication.  The causes and consequences of centrosome 
amplification will be discussed, and the members of the polo-like family of kinases 
will be introduced.   
 
Structure of the centrosome 
The centrosome is a small non-membraneous organelle occupying approximately 
1µm3 of cell volume and is usually found in close proximity to the nucleus (Doxsey, 
2001; Bornens, 2002; Gall, 2004; Azimzadeh and Bornens, 2004).  It functions as the 
microtubule organising centre (MTOC) in interphase cells and is essential to the 
formation of cilia.  These functions are conserved in evolution across a wide variety 
of exclusively eukaryotic organisms (Beisson and Wright, 2003), with the exception 
of higher plants and certain fungi that are thought to have lost the ability to form this 
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organelle.  Specifically, retention of centrosomes may correlate with the maintenance 
of flagellated gametes or stages in an organism’s reproductive cycle.   
The mammalian centrosome comprises a pair of orthogonally arranged 
centrioles surrounded by the fibrous pericentriolar matrix (PCM), an electron dense 
structure containing proteins required for microtubule nucleation (Fig. 1) (Doxsey, 
2001; Mority, 2004).  The PCM thus provides docking sites for numerous proteins 
involved in this process, notably members of the γ-tubulin ring complex (γTuRC) but 
also larger coiled-coil proteins such as AKAP450, BBS4 and PCM-1 (Keryer et al., 
2003a; Balczon et al., 1994)   
 
 
 
 
 
Figure 1. Structure of the centrosome.  Schematic diagram depicting the centrosome consisting of 
the centrioles and the surrounding PCM.  (Doxsey, 2001) 
 
Embedded within the surrounding PCM, two centrioles are composed of a 
symmetrical barrel-shaped array of nine triplets of microtubulules generally 400 nm.  
Basal bodies found at the base of the cilium are identical in nature to centrioles 
(Beisson and Wright, 2003).  Several proteins are found at centrioles, in particular δ-
tubulin, centrins-2 and -3 and polyglutamylated β-tubulin (Dutcher, 2001; Salisbury et 
al., 2002; Azimzadeh and Bornens, 2004; Bobinnec et al., 1998).  However, the two 
centrioles are structurally dissimilar.  Several proteins are only found on the fully 
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matured centriole (or mother centriole) which is characterised by the presence of 
appendages where proteins such as ε-tubulin (Chang et al., 2003), ninein (Mogensen 
et al., 2000), odf2 (Ishikawa et al., 2005) or cep170 (Guarguaglini et al., 2005) are 
located. 
Centrioles are integral to the whole structure of the centrosome.  When 
antibodies against polyglutamylated tubulin are microinjected into cells, centrioles 
disassemble and the PCM is seen to disperse (Bobinnec et al., 1998).  Centrioles 
therefore determine the site of PCM accumulation.  Secondly, centrioles determine 
the reproductive capacity of the centrosome.  When centrosomes are stripped of 
centrioles in sea urchin zygotes, the PCM is no longer capable of duplicating (Geissler 
et al., 1996; Salisbury, 2004)  
Although the centriole is evolutionarily conserved across a wide variety of 
organisms, it has undergone structural alterations.  In particular, the centriole in the 
fruit fly (Drosophila melanogaster) and the nematode (Caenorhabditis elegans) is 
characterised by a reduction in the number of microtubules, namely doublets and 
singlets, respectively (Raff, 2004; Delattre and Gonczy, 2004). Conversely, plants 
have generally lost the ability to form centrioles.  Notable exceptions include several 
lower plants, such as bryophytes, cycads and Ginkgo which are able to form de novo 
centriole-like structures during gametogenesis.  These sometimes accumulate forming 
giant agglomerations called blepharoplasts (Gall, 2004).  In contrast, yeast have a 
functionally equivalent structure called the spindle-pole body (SPB), albeit of entirely 
different organisation (van Kreeveld Noane and Winey, 2004).  Despite its divergent 
structure, some components of the SPB have distantly related proteins in the 
mammalian cell, thus revealing conserved roles for proteins in organelle structure and 
microtubule nucleation.   
 
The centrosome cycle 
The centrosome cycle is commonly classified as a sequence of four events: centriole 
disorientation, centriole duplication, centrosome disjunction and centrosome 
separation (Figure 2)(Sluder, 2004).  The distinctions between each event are based 
on morphological changes that are observable by light and electron microscopy 
(Kuriyama and Borisy, 1981; Chretien et al., 1997). The individual steps of the 
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centrosome cycle occur during different stages of the cell cycle (summarised in Figure 
2).   
 
 
 
Figure 2.  The centrosome cycle.   
Schematic diagram showing the different stages of the centrosome cycle during the phases of cell 
division.  Centrioles are in dark blue, the PCM in light blue. 
 
 
The earliest event considered important for centriole duplication is centriole 
disorientation (Freed et al., 1999).  This event takes place during late M- or G1 phase 
and involves the action of SCF ubiquitin ligase components and the proteasome 
(Freed et al., 1999).  At this stage, centrioles lose their orthogonally paired 
relationship and in some cells are observed to separate widely, such as in HeLa cells 
(Piel et al., 2000). Although the significance of centriole disorientation for the process 
of centrosome reproduction remains unclear, centrioles have been observed to travel 
extensively, an action that has been proposed as essential for the completion of 
cytokinesis (Piel et al., 2001).   
Centriole duplication begins with the appearance of short pro-centrioles at right 
angles to the proximal ends of the parental centrioles during G1/S or early S phase 
(Kuriyama and Borisy, 1981; Robbins et al., 1968; Vorobjev and Chentsov, 1982; 
Alvey, 1985; Kochanski and Borisy, 1990; Paintrand et al., 1992).  Studies using 
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microinjection of biotinylated γ-tubulin have demonstrated that recruitment of 
labelled tubulin only takes place at the nascent centriole, revealing a conservative 
mode of centriole assembly (Kochanski and Borisy, 1990).  Procentrioles elongate 
during the S-phase and attain their final length during G2.  Although having then 
reached full size, the new daughter centrioles only mature by acquiring distal and sub-
distal appendages in the following cell cycles.  Although the description of centriole 
duplication steps are based on observational data, it has been put forward that the 
physical appearance of nascent daughter centrioles could follow on from earlier 
molecular events undetectable by present microscopic techniques (Sluder, 2004).   
After centrioles have duplicated, a putative physical link between the two 
parent-daughter centriole pairs is cut, resulting in a semi-conservative distribution of 
centrioles to the two resulting centrosomes (Figure 2).  At present, the composition of 
this linker is unknown.  However, centrosome separation is thought to be regulated by 
the phosphorylation status of C-Nap1, a protein located at the proximal ends of the 
parental centriole and which may act as a docking site for other linker proteins (Fry et 
al., 1998; Mayor et al., 2000).  The phosphorylation status of this protein is 
maintained in a balance by the centrosomal kinase Nek2 and its antagonistic protein 
phosphatase 1α (PP1α), which is inactivated at the beginning of mitosis (Meraldi and 
Nigg, 2001).  Dephosphorylation of C-Nap1 leads to its displacement from the 
proximal centriole end during mitosis, thus allowing centriole separation to proceed 
through the action of plus and minus-end directed microtubule motor proteins.  
Additionally, the centrosomal protein rootletin, a component of the ciliary rootlet of 
retinal cells, has been recently described as an interactor of C-Nap1 and as a substrate 
of Nek2 (Bahe et al., 2005).  Rootletin forms fibres emanating from the proximal ends 
of centrioles.  Its depletion leads to precocious centriole splitting and accordingly, 
rootletin has been proposed to form part of the linker structure.   
Other proteins are also involved in centrosome separation.  A report suggests 
that the activity of the phosphatase Cdc14A may also be implicated (Mailand et al., 
2002).  Depletion of this phosphatase results in a lack of separation whereas an excess 
of Cdc14A leads to a loss of centrosome cohesion.  Similarly, siRNA mediated 
depletion of dynamin 2, a large GTPase involved in vesicle formation and actin 
organisation, results in centrosome splitting (Thompson et al., 2004).  Furthermore, 
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centrin phosphorylation has also been thought to play a role in this process (Lutz et 
al., 2001). 
The centrosome cycle is completed in G2 by a maturation step characterized by 
a large increase in centrosome size caused by the recruitment of additional γ-tubulin 
ring complexes (Palazzo et al., 2000).  Concomitantly, the levels of microtubule 
nucleation are drastically increased (Palazzo et al., 2000).  Furthermore, maturation is 
distinguished by the recruitment of additional centrosomal proteins such as NuMA 
(Merdes et al., 1996) and Plk1 (Golsteyn et al., 1995; Lane and Nigg, 1996) while 
others are lost.  Plk1 has been shown to regulate Nlp, a centrosomal protein that is 
involved in binding γ-tubulin ring complexes and nucleating microtubules (Casenghi 
et al., 2003; Casenghi et al., 2005).  Furthermore, Aurora A (Berdnik and Knoblich, 
2002; Hannak et al., 2001), Cdk11 (Petretti et al., 2006) and the posphatase PP4 
(Helps et al., 1998; Sumiyoshi et al., 2002) have been implicated in centrosome 
maturation although the underlying mechanisms are still unknown.   
 
Regulation of  centriole duplication 
How the parent centriole is able to control the assembly of a single daughter centriole 
perpendicularly to its surface remains a mystery.  At present, a hypothesis has been 
proposed that a templating mechanism determines a docking site at the proximal end 
of the mother centriole to which centriolar proteins are recruited (Sluder, 2004; 
Delattre and Gonczy, 2004).  Parallels are seen in yeast, where the half-bridge 
structure of the new spindle pole body defines the site of duplication in the next cell 
cycle (Francis and Davis, 2000; van Kreeveld Noane and Winey, 2004).  A similar 
structure has not been observed in mammalian cells, thus the question remains 
whether a template exists and how it is restricted to one proximal site.  Interestingly, 
cells from a temperature sensitive mutant of Cdk1 in Drosophila show prolonged S-
phases and abnormal centriole duplication (Vidwans et al., 2003).  Some of these cells 
exhibit daughter centrioles of increased length or parental centrioles with two or more 
daughter centrioles.  Furthermore, centriole lengths vary in different tissues in 
Drosophila (Raff, 2004).  The centrioles of the developing spermatocyte crypt are 
very long and are thus particularly suitable for microscopic analysis. Therefore, it 
seems plausible that centriole length and the number of assembly sites are not 
structurally restricted but instead are subject to regulatory mechanisms.   
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Uncoupled centriole propagation is thought to occur de novo in the absence of a 
putative templating mechanism (Beisson and Wright, 2003).  In particular, 
differentiating ciliated epithelial cells generate multiple basal bodies from a putative 
structure called the deuterosome (Beisson and Wright, 2003).  Similarly, cells whose 
centrioles have been removed by laser ablation are able to reform microtubule 
organizing centres containing centrioles, albeit at multiple copy numbers (Khodjakov 
et al., 2002).  Furthermore, in the mouse zygote, centrioles are not detectable until 
several cell divisions after fertilization (Szollosi et al., 1972; Delattre and Gonczy, 
2004), and are found in parthogenetically dividing sea urchin eggs (Kallenbach and 
Mazia, 1982).  The number of centrioles and the mode of replication may therefore be 
variable and under developmental control.   
For most cells, the rule that the centrosome must be restricted to a single 
duplication only once per cell cycle holds true.  Earlier studies by Mazia and co-
workers using sea-urchin zygotes revealed a regulatory mechanism that maintains the 
number of centrosomes to one, and which is dependent on the number of centriole 
pairs present in the cell (Sluder, 2004).  Centrioles in these zygotic cells were 
artificially induced to split by a prolongued prometaphase delay, resulting in the 
formation of tetra-polar spindles.  These poles contained only a single centriole which 
was incapable of splitting any further.  The generated daughter cells therefore 
contained one centrosome with only one centriole.  This single centriole was then 
seen to duplicate but not split during subsequent cell cycles, thus maintaining proper 
centrosome numbers.  Consequently,  the number of centriole pairs was found to 
determine the number of centrosomes under normal circumstances.   
Cells do not have a checkpoint to stop the cell cycle in the presence of multiple 
centrosomes (Sluder et al., 1997).  Instead, cells have a mechanism to prohibit excess 
centrosome duplication, as revealed by a study using mammalian cells (Wong and 
Stearns, 2003).  Cells from different phases of the cell cycle were fused to assay 
whether previously duplicated centrosomes would reduplicate in an S-phase 
cytoplasm.  Fusion of a G1 and a G2 cell revealed that the G1 centrosome was 
competent for duplication whereas the G2 was not, even though both were in an S-
phase cytoplasm permissive for duplication.  This intriguing result suggested that a 
duplication inhibitor must reside on the G2 centrosome itself.  Conversely, several 
mammalian cell lines lack this control mechanism and are capable of breaking the 
‘once-per cell cycle’ rule.  In particular, CHO and U2OS cells subjected to a 
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prolonged S-phase arrest are able to overduplicate their centrosomes (Balczon et al., 
1995).  Taken together, cells have regulatory mechanisms to maintain centrosome 
numbers and limit their reproduction during the cell cycle.   
 
Cdk2-cyclinA/E regulates centrosome duplication 
A sensible manner to control timely centrosome reproduction would be to link this 
process to DNA replication.  Indeed, evidence has accumulated supporting a role for 
the cyclin dependent kinase 2 (Cdk2) together with cyclin A/E in regulating centriole 
duplication (Sluder, 2004).  Initial data was obtained from mammalian somatic cells 
competent for multiple rounds of centrosome duplication when arrested in S-phase.  
When Cdk2 activity in these cells was blocked by treatment with roscovitin, a potent 
inhibitor of Cdks, or by overexpression of the Cdk-inhibitor protein p21, centrosome 
reduplication was inhibited (Matsumoto et al., 1999b; Meraldi et al., 1999a).  A 
similar result was obtained by transfecting cells with a phosphorylation site mutant of 
the Retinoblastoma protein, a tumour suppressor that must be phosphorylated to 
promote the expression of genes required for mitosis.  This block could be relieved by 
contransfecting with Cdk2-cyclin A whereas cyclin E could not (Meraldi et al., 
1999a).  These studies therefore highlighted the role of Cdk2-cyclin A in mammalian 
centrosome reproduction.   
In parallel, studies using S-phase arrested Xenopus egg extracts confirmed the 
requirement of Cdk2-cyclin E for centrosome duplication (Hinchcliffe et al., 1999b; 
Lacey et al., 1999).  In these studies, egg extracts were arrested in S phase allowing 
multiple rounds of reduplication of exogenous sperm centrioles.  Centriole duplication 
was inhibited when a truncated version of  Xenopus p27, a Cdk-inhibitor protein 
related to p21, was added to the extract.  Conversely, centrosome duplication was 
restored with an excess of purified Cdk2-cyclin E.  Since Cdk2-cyclin A is not active 
in Xenopus zygotes early on (Rempel et al., 1995), these results suggest that only 
Cdk2 complexed with cyclin E was essential for centrosome duplication.  However, 
differences may be explained by the assays used, pointing to an involvement of cyclin 
E early in zygotic development and cyclin A later on in somatic cells.   
However, explanations involving these two cyclins become more complex when 
results from knockout mice are taken into consideration (Roberts and Sherr, 2003; 
Traganos, 2004; Aleem et al., 2004).  Cdk2 knockout mice are largely viable and 
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show only minor defects in germ cell development (Berthet et al., 2003; Berthet et al., 
2003), suggesting that Cdk2 is not strictly required for cell proliferation.  Likewise, 
mice deficient in cyclin E1 and cyclin E2 as well as the double knockout mouse 
proceed with normal development until the 10th day of gestation (Geng et al., 2003), 
indicating that cell proliferation can occur in the absence of cyclin E.  While cyclin 
A1 is not necessary for normal mouse development with the exception of gametes 
(Liu et al., 1998), a lack of cyclin A2 results in embryonic lethality (Murphy et al., 
1997).  It has therefore been proposed that cells are able to survive with only cyclins 
A2 and B complexed with Cdk1, and that these Cdk-cyclin complexes are sufficient 
to perform all necessary functions to drive the cell through S and M phases of the cell 
cycle (Roberts and Sherr, 2003). Taking this into consideration, it would appear likely 
that certain cyclins and Cdks are redundant or have particular developmental or tissue 
specific functions.  However, how these data explain the requirement of Cdk2 in 
cultured mammalian cells, or whether a particular Cdk-cyclin complex is uniquely 
required for centriole duplication, remains unclear.   
 
Other kinases required for centrosome duplication 
Studies using the Xenopus egg extract system have revealed a role of 
Calcium/Calmodulin-dependent kinase II (CamKII) in centriole duplication 
(Matsumoto and Maller, 2002).  Similar to the investigation of the role of Cdk2-cyclin 
E in this process, S-phase arrested egg extracts supportive of multiple cycles of 
centriole duplication were used.  Centriole duplication was blocked when calcium 
signalling was inhibited by the use of chelating agents or an inhibitor of inositol 1,4,5 
trisphosphate receptor mediated calcium oscillations.  When CamKII was directly 
inhibited by the addition of a pseudosubstrate peptide to the egg extract, a similar 
result was observed.  Furthermore, centriole duplication could be restored in these 
extracts by the addition of excess CamKII together with calmodulin.  In contrast to 
the effects of Cdk2-cyclin E inhibition which led to a block after the first round of 
centriole duplication, inactivation of CamKII prevented centriole duplication right 
from the beginning.  This intriguing result could point to a role of CamKII in kick-
starting centriole duplication in response to early calcium signalling events such as 
those caused by fertilization (Sluder, 2004). 
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A screen for genes necessary for embryonic development of C. elegans 
uncovered Zyg-1, a kinase essential for all developmental stages (O'Connell et al., 
1998).  An elegant analysis of the earliest divisions of the C. elegans embryo using 
reciprocal crosses between wild type and mutant parents revealed the requirement of 
this kinase in centriole duplication (Figure 3) (O'Connell et al., 2001).   
 
 
 
 
Figure 3. Zyg-1 is necessary for centriole duplication in C. elegans.  Schematic diagram showing 
the two different phenotypes obtained for Zyg-1 mutants in early embryos.  Normal embryos obtain a 
pair of centrioles from sperm and proceed through mitosis forming two daughter centrioles with normal 
centriole numbers (a,b,c).  In a maternal Zyg-1mutant background, the wild type centrioles are unable 
to duplicate but split and form a bipolar spindle.  The two resulting daughter cells only have one 
centriole each (d, e, f).  Sperm centrioles do not duplicate in a paternal Zyg-1 mutant.  Thus, the wild 
type oocyte is fertilised with only one centriole from mutant sperm (g), which then duplicates normally 
but only forms a monopolar spindle (h) and does not pass through cytokinesis (i). (Hinchcliffe and 
Sluder, 2001) 
 
When mutant embryos were fertilised with wild type sperm, the parentally 
inherited centrioles split and formed a bipolar spindle during the first embryonic 
cleavage, but were unable to duplicate in subsequent cell divisions resulting in 
monopolar spindles (Figure 3).  Zyg-1 is also required for centriole duplication during 
spermatogenesis, thus mutant sperm cells can only donate a single centriole to the 
wild type embryo upon fertilization.  This single centriole was observed to duplicate 
correctly in the wild type cytoplasm containing maternal Zyg-1, but only formed a 
monopolar spindle.  Immunofluorescence data places this kinase at the centrosome 
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during anaphase-telophase when centriole duplication begins in early embryos.  Zyg-1 
therefore is present at the centrosome at the right time.  However, a direct substrate 
for this kinase has not been found nor have any homologues been identified in other 
organisms.   
Reports have indicated a function in centriole duplication for human Mps1 (Fisk 
et al., 2003).  Studies have focused on this kinase as the yeast homologue is necessary 
for duplication of the spindle pole body (Winey et al., 1991).  However, other groups 
have disputed the the proposed centrosomal function of this kinase and instead 
provide data revealing a role for Mps1 in the spindle checkpoint in both mammalian 
cells and Drosophila (Stucke et al., 2002; Fischer et al., 2004). 
 
 The C. elegans proteins Sas-4, Sas-5 and Sas-6 
The C. elegans centriole is different in many aspects to its mammalian counterpart.  It 
consists of nine singlets of microtubules and lacks appendage structures (Delattre and 
Gonczy, 2004).  Furthermore, important proteins involved in mammalian centriole 
duplication are missing, including ε-tubulin and centrin (see below).  Although the 
underlying mechanisms of this process may therefore differ significantly in C. elegans 
when compared to other organisms, studies using this model organism may reveal 
functionally conserved mechanisms.   
Large siRNA screens have identified Sas-4 and Sas-6 as two proteins essential 
for centriole duplication in C. elegans (Leidel and Gonczy, 2005).  Although mutants 
of these proteins assemble a normal bipolar spindle during the first cleavage division, 
a monopolar spindle is formed in the two daughter cells due to reduced centriole 
numbers (Dammermann et al., 2004; Kirkham et al., 2003; Leidel et al., 2005; Leidel 
and Gonczy, 2003).  Studies using fluorescence recovery after photobleaching 
(FRAP) demonstrate that Sas-4 and Sas-6 are recruited to the centriole at the onset of 
daughter centriole formation (Leidel et al., 2005; Leidel and Gonczy, 2003).  
However, Sas-4 is solely recruited to the nascent centriole whereas Sas-6 is present on 
both centrioles.  Interestingly, Sas-6 is not found on centrioles in a Sas-4 depleted 
cytoplasm, revealing a protein recruitment function for Sas-4.  Indeed, Sas-4 has been 
proposed to play a role in controlling PCM size (Kirkham et al., 2003) by regulating 
protein recruitment.  Alternatively, Sas-4 has been proposed to control centriole 
length thus indirectly affecting the size of the PCM (Leidel and Gonczy, 2005).   
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Both Sas-4 and Sas-6 have mammalian homologues.  The human counterpart of 
Sas-4 is the protein CPAP (centrosomal P4.1-associated protein) which has been 
shown to interact with γ-tubulin and was found in a mass-spectrometric analysis of the 
centrosome (Andersen et al., 2003; Hung et al., 2000).  Unfortunately, it is not known 
whether CPAP is essential for mammalian centriole duplication.  However, depletion 
of human Sas-6 from cell lines by siRNA inhibits centriole duplication and, 
intriguingly, a percentage of cells overexpressing human Sas-6 show excess 
centrioles, suggesting that a surfeit of this protein results in centriole overduplication 
(Leidel et al., 2005).   
Like the two previous C. elegans proteins, Sas-5 has been identified by siRNA 
screens as a protein required for centriole formation (Delattre et al., 2004).  This 
coiled-coil protein is dynamically recruited to the centriole throughout the cell cycle 
and has been shown to interact with Sas-6 in a yeast two-hybrid assay.  Furthermore, 
the recruitment of both Sas-5 and Sas-6 to the centriole is dependent on the activity of 
Zyg-1 (Delattre et al., 2004), but neither protein has been shown to act as a substrate 
for this kinase.  Taken together, these data suggest Zyg-1 is required for the targeting 
of Sas-5 and -6 to the centriole, allowing these proteins to recruit further proteins such 
as Sas-4 that are required for centriole assembly.   
Finally, SPD-2 has the dual role of being required for PCM recruitment to the 
C. elegans centrosome and for centriole duplication (Pelletier et al., 2004; Kemp et 
al., 2004).  Like the other centriole proteins discussed so far, SPD-2 is a large coiled-
coil protein that has homologues in other organisms.  In particular, a human 
homologue, Cep192, has been identified as a centrosomal protein (Andersen et al., 
2003) but its function has not been elucidated. 
In summary, there are five C. elegans proteins identified so far that are required 
for centriole duplication in the early embryo.  These are Sas-4, -5 and -6 together with 
SPD-2 and the kinase Zyg-1.  It is as yet unclear whether any more proteins remain 
undiscovered, or whether these five proteins are sufficient for centriole duplication in 
the nematode worm.  However, since some of the homologues of these proteins are 
found in other organisms, it is likely that a similar core set of proteins could be 
functionally conserved in regulating human centriole duplication.   
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Other proteins required for centriole duplication  
Other proteins have been identified in mammalian cells that are necessary for the 
duplication of centrioles (Table 1).  Several of these contain extensive coiled-coil 
regions hinting at a structural role for these proteins.  In particular, when the PCM is 
disturbed by the overexpression of a dominant negative form of the large coiled-coil 
protein AKAP450, centriole duplication is inhibited (Keryer et al., 2003b).  Recently, 
the coiled-coil domain containing protein centrobin has been reported to function in 
centriole duplication (Zou et al., 2005).  Interestingly, this protein localises to the 
newly forming daughter centriole and thus resembles Sas-4 in this manner.   
Two proteins have been identified as substrates of Cdk2.  CP110 is a large 
coiled-coil protein necessary for centriole reproduction (Chen et al., 2002a), as is 
nucleophosmin (Okuda et al., 2000; Tokuyama et al., 2001); reviewed in (Okuda, 
2002).  Overexpression of a non-phosphorylatable mutant of nucleophosmin was 
shown to block centriole duplication.  Further work revealed that mice deficient of 
nucleophosmin died early in embryogenesis and MEFs exhibited centrosome 
amplification and genomic instability (Grisendi et al., 2005).   
Members of the tubulin family of proteins have also been implicated in centriole 
duplication.  γ-tubulin, an essential component of the γ-tubulin ring complexes 
involved in microtubule nucleation, is required for proper centrosome duplication in 
certain unicellular organisms (Ruiz et al., 1999; Shang et al., 2002).  The related ε-
tubulin, found to localise to centriole appendages, is also required (Chang et al., 
2003).  Moreover, two recent reports highlighted the role of NEDD1, another γ-
tubulin ring complex component, in the maintenance of centriole numbers (Haren et 
al., 2006; Luders et al., 2006).   
Some proteins essential to centriole duplication are conserved in evolutionarily 
distant organisms.  The centriolar marker centrin-2 has been reported to function in 
this process and is an homologue of yeast Cdc31p (Salisbury et al., 2002; Middendorp 
et al., 2000; Baum et al., 1986), a protein that localises to the spindle pole body and is 
required for the duplication of this organelle (van Kreeveld Noane and Winey, 2004).  
Interestingly, centrins are Ca2+-binding proteins related to the Calmodulin superfamily 
and are thought to form Ca2+ dependent fibres (Adams and Kilmartin, 2000).  
Likewise, the Cdc31p interactor Sfi1p is found in the spindle-pole  
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Table 1 Summary of proteins involved in centriole duplication.   
 
 
body half bridge structure and depletion of this protein results in defective spindle-
pole body replication (Kilmartin, 2003).  Sfi1p is thought to bind multiple copies of 
Cdc31p through its multiple coiled-coil repeats, thus potentially forming a fibrous 
linker structure required for the integrity of the spindle-pole body.  However, it is not 
known whether the human homologue of Sfi1p has a similar function.   
Gene Species References 
Kinases   
Zyg-1 C. elegans (O'Connell et al., 2001) 
Cdk2-cyclin E/A Human, Xenopus (Matsumoto et al., 1999a; Meraldi et al., 
1999a; Lacey et al., 1999) 
CamKII Xenopus (Matsumoto and Maller, 2002) 
Plk2 Human (Warnke et al., 2004) 
Sas-4,  Sas-6  C. elegans (Leidel et al., 2005; Leidel and Gonczy, 
2003; Dammermann et al., 2004) 
Sas-5 C. elegans (Delattre et al., 2004) 
SPD-2 C. elegans (Pelletier et al., 2004) 
CP110 Human (Chen et al., 2002a)  
Centrin Human (Salisbury et al., 2002) 
AKAP450 Human (Keryer et al., 2003b) 
ε-tubulin Xenopus (Chang et al., 2003) 
γ-tubulin Paramecium, tetrahymena (Ruiz et al., 1999) 
NEDD1 Human (Haren et al., 2006; Luders et al., 2006) 
centrobin Human (Zou et al., 2005) 
PML3 Human (Xu et al., 2005) 
SHD1 Human (Khuda et al., 2004) 
ID1 Human (Hasskarl et al., 2004) 
STAT3 Human (Metge et al., 2004) 
E7 Human Papilloma Virus (Duensing and Munger, 2003) 
E2F3 Human (Saavedra et al., 2003) 
SCF components Xenopus, Drosophila, mouse (Freed et al., 1999; Guardavaccaro et al., 
2003; Murphy, 2003; Wojcik et al., 2000) 
nucleophosmin Human (Okuda et al., 2000; Tokuyama et al., 2001) 
p53 Human (Tarapore et al., 2001) 
BRCA1, Gadd45 Human (Tutt et al., 1999; Wang et al., 2004; Hut et 
al., 2005) 
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It is also apparent that regulation of centriole duplication requires several 
components of the SCF ubiquitin ligase complex and the proteasome (Freed et al., 
1999).  Mutations in the Drosophila skp1 homologue results in centriole 
overduplication (Murphy, 2003; Wojcik et al., 2000).  Mice deficient for SCF-βTrcp1 
were found to contain cells with excess centrosomes.  This protein has therefore been 
proposed to degrade a licensing factor that normally restricts centriole duplication to 
one round per cell cycle (Guardavaccaro et al., 2003).   
The centrosome cycle is also the target of viral oncogenic proteins.  
Specifically, the high-risk human papilloma virus protein E7 induces centriole 
overduplication when overexpressed in primary cells (Duensing et al., 2001); 
(Duensing and Munger, 2001).  Infection with High-risk human papilloma viruses can 
result in the formation of malignant tumours.  Accordingly, the centrosome 
overduplication phenotype resulting from overexpression of this viral protein is 
thought to contribute to the genomic instability and transformation of infected cells.   
 
Origins of centrosome amplification and possible consequences 
From observational studies of abnormal cell divisions in horse nematode eggs 
(Ascaris megalocephala), Boveri proposed a link between centrosome number, 
chromosome aneuploidy and cancer (Goepfert and Brinkley, 2004).  This proposal 
has gained renewed interest with the discovery that several types of tumour cells 
exhibit centrosome amplification (Fukasawa et al., 1996; Lingle et al., 1998; Pihan et 
al., 1998; Ghadimi et al., 2000); reviewed in (Nigg, 2002; Nigg E.A., 2004).  Boveri 
noticed that, in their role as MTOCs, supernumerary centrosomes usually lead to the 
formation of multipolar spindles and aberrant mitosis, thus providing a route to 
chromosome missegregation and aneuploidy (reviewed in (Goepfert and Brinkley, 
2004).  However, in tumour cells it is not clear whether deregulation of centrosome 
numbers precedes aneuploidy, or if centrosome amplification is a consequence of 
mitotic errors induced by transformation (Nigg, 2002). 
Four possible mechanisms exist that allow cells to acquire additional 
centrosomes (Figure 4).  Deregulated centriole duplication may occur by defects in 
the mechanism that ensures duplication is restricted to once per cell cycle (Wong and 
Stearns, 2003).  As mentioned previously, primary cells tightly control centriole 
numbers whereas some transformed cell lines, such as CHO and U2OS cells, permit 
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reduplication during a prolonged S-phase (Meraldi et al., 1999a; Balczon et al., 1995). 
Experimentally, centriole overduplication can also be induced by overexpression of 
human Sas-6 (Leidel et al., 2005).  Similarly, additional MTOCs may be obtained by 
splitting existing centriole pairs, or by overexpressing PCM components that lead to 
the formation of centrosome fragments with microtubule nucleating abilities.  
Regardless of the cause, all lead to the generation of diploid cells with abnormal 
numbers of centrosomes.  
 
 
 
 
Figure 4. The origins of centrosome amplification.  A schematic diagram showing four pathways for 
acquiring extra copies of centrosomes.  (adapted from (Goepfert and Brinkley, 2004) 
 
A failure of cell division may have several causes unrelated to centrosome biology but 
nevertheless lead to centrosome amplification and polyploidy, the latter a feature that 
has been shown to result in tumorigenesis (Fujiwara et al., 2005).  Mutational 
activation or inactivation of genes involved in cell cycle events such as cytokinesis, 
DNA damage repair or the spindle-assembly checkpoint are possibly the most 
common causes resulting in cell division failure.  In particular, p53, BRCA1 and some 
of their interactors were thought to be genuine regulators of the centrosome cycle 
(Tarapore et al., 2001); (Tutt et al., 1999; Wang et al., 2004; Hut et al., 2005).   
However, these findings have been questioned (Hut et al., 2005; Nigg, 2002).  
Similarly, overexpression of Aurora A, a kinase thought to regulate centrosome 
 20
 
numbers, has been observed to induce a cytokinesis failure in cells (Meraldi et al., 
2002b).  Therefore, several proteins presented in Table 1 may not be involved in 
centriole duplication, but actually achieve centrosome amplification indirectly by 
other means.   
Several outcomes can befall cells with supernumerary centrosomes (Brinkley, 
2001; Sluder and Nordberg, 2004).  For example, p53-/- mouse embryonic fibroblasts 
(MEFs) with excess centrosomes usually formed multipolar spindles that mostly lead 
to cell death, presumably through loss of genetic material (Sluder and Nordberg, 
2004).  In rare cases when cells manage to survive aneuploidy and form progeny cells, 
excess centrosomes may coalesce into large MTOCs or have their microtubule 
nucleating capabilities silenced (Brinkley, 2001).  Alternatively, cells with multiple 
centrosomes and aberrant spindles persist in tumour cell lines and are thought to be 
continually removed by apoptosis (Lingle and Salisbury, 1999).  Surplus centrosomes 
may therefore cause initial events required for cancer formation, but are a 
disadvantage to dividing tumour cells.   
 
Polo-like kinases 
The polo-like kinases (Plks) are structurally related serine/threonine kinases that are 
essential regulators of mitotic and meiotic progression in diverse organisms ranging 
from yeast and humans (Figure 5) (Barr et al., 2004; Lee et al., 2005; Winkles and 
Alberts, 2005; Glover, 2005).  Their name derives from a Drosophila mutant (Polo) 
that fails to complete normal mitosis, and which exhibited abnormal spindle and 
centrosome morphology (Sunkel and Glover, 1988; Llamazares et al., 1991), thus 
pointing to a role for Plks in mitotic events.  In humans, four Plks have been identified 
and are known as Plk1, Plk2 (Snk), Plk3 (Fnk, Prk) and Plk4 (Sak) (Barr et al., 2004).  
Other organisms have reduced numbers of Plk-related genes; three are found in C. 
elegans, two in Drosophila (Polo and DmSak) and one in single cell eukaryotes 
(Cdc5, Plo1).  The conservation of Plks in evolutionarily distant organisms indicates a 
function essential to life, and the increase in Plk orthologues may be related to the 
increased complexity of regulating cell division, polarity and checkpoints in 
multicellular organisms.   
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Figure 5. Members of the polo-like kinase family from different model organisms.  All Plks share 
an N-terminal kinase domain (red) and two C-terminal polo-box domains (pbd, green), the exception 
being Plk4 with only one polo-box. The putative Plk4 cryptic polo-box, which is only loosely defined, 
is shown in yellow.  For comparison, the mouse Plk4 sequences are included.  The insertion found in 
human but not mouse Plk4 is shown in blue (adapted from (Dai, 2005). 
 
 
Plks share an N-terminal kinase domain that is highly conserved and shows 
homology to other serine/threonine kinases (Figure 5)(Barr et al., 2004; Lowery et al., 
2005; Dai, 2005).  The catalytic activity of this domain is essential for  Plks to fulfil 
their respective cellular functions.  Most significantly, Plks are defined by their 
possession of the structural polo-box domain, located in the C-terminal region (Cheng 
et al., 2003; Elia et al., 2003b; Elia et al., 2003a).  The Plk1 polo-box domain has been 
shown to bind phosphorylated serine/threonines found within a consensus peptide 
motif, and it is likely that the polo-box domains of other Plk family members behave 
similarly.   
Plks regulate several events important for cell division such as centrosome 
maturation, onset of mitosis, bipolar spindle formation, chromosome segregation, 
Golgi fragmentation and cytokinesis (Barr et al., 2004).  Plk2 and 3 also function in 
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events unrelated to the cell cycle.  However, the similarity of human Plk homologues 
raises the question whether some of these, in particular Plk2 and Plk3, have redundant 
functions.    
Plk1 
Plk1 and its orthologues in other organisms are the best characterised members of the 
Polo-like kinase family (Barr et al., 2004);(Lowery et al., 2005; van Vugt and 
Medema, 2005) but a full treatise of the current knowledge would be beyond the 
bounds of this introduction.  Only a short summary of the most salient features will 
therefore be given here.   
Plk1 functions in centrosome maturation, spindle formation, chromosome 
cohesion and cytokinesis (Figure 6)(Barr et al., 2004) and has been implicated in 
tumorigenesis (Strebhardt and Ullrich, 2006).  During the multiple stages of the 
mammalian cell cycle, Plk1 localises to various intracellular structures, appearing 
sequentially at the centrosome, the kinetochores and finally at the spindle mid-zone 
(Golsteyn et al., 1995).   
 
 
Figure 6.  The multiple functions of Plk1.  Schematic diagram showing the involvement of Plk1 in 
the various processes during the cell cycle.  Structures to which Plk1 localises are in red (Barr et al., 
2004).   
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The localisation of Plk1 and its interaction partners depends on a functional 
polo-box domain (Lee et al., 1998; Hanisch et al., 2006).  As mentioned above, the 
polo-box domain has been identified as a phosphopeptide-binding motif (Elia et al., 
2003a) and structural analysis of the crystallised domain revealed the molecular 
interactions between the polo-box interface and phosphorylated target sequences (Elia 
et al., 2003b; Cheng et al., 2003).  Briefly, the human Plk1 polo-box domain contains 
the conserved residues His538 and  Lys540 that directly interact with phospho- serine 
and threonine residues.  This interaction is stabilised by van der Waals interactions 
and aided by hydrogen bonds involving water molecules and other conserved polo-
box residues (Elia et al., 2003b; Cheng et al., 2003).  Furthermore, the interacting 
residues sit in a cleft jointly formed by both polo-box motifs 1 and 2. 
The optimal sequence motif with is recognised by the polo-box domain is S-
pS/T-P/X and is reminiscent of Cdk and MAPK target phosphorylation sites (Elia et 
al., 2003a).  Therefore, two models of how the Plk1 polo-box domain might function 
have been proposed (Figure 7) (Lowery et al., 2005).  
 
 
 
 
Figure 7.  Activation of Plk1 and binding to primed substrates.  Docking proteins are 
phosphorylated by upstream priming kinases allowing phospho-dependent binding of Plk1 via the 
polo-box domain.  Together with kinases directly activating Plk1 by phosphorylating the T-loop of the 
catalytic domain, binding relieves polo-box mediated auto-inhibition of Plk1 (Barr et al., 2004).   
 
 
In one model, the polo-box domain binds to a site on a docking protein that has 
been ‘primed’ by previous phosphorylation by an upstream kinase.  The interaction 
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with the docking protein would target Plk1 in proximity to substrates and therefore 
introduce an important element of spatial control.  The sequential localisation of Plk1 
from centrosomes to kinetochores and spindle midzone as cells pass through mitosis 
is consistent with this model.  Alternatively, Plk1 interactors would contain both polo-
box binding sites and Plk1 phosphorylation motifs.  Such a mechanism has recently 
been shown for the phospho-dependent binding of Plx1 to XErp-1, a factor whose 
phosphorylation by Plx1 and subsequent degradation is required for the release of 
Xenopus oocytes from meiosis II, and which depends on prior phosphorylation of a 
polo-box binding site by CamKII (Schmidt et al., 2005; Rauh et al., 2005).  
In either case, Plk1 is thought to act as an integrator of upstream 
phosphorylation events by other mitotic kinases or by its own activity (Barr et al., 
2004).  Binding to phospho-serine and –threonine residues via the polo-box domain 
only takes place if upstream mitotic kinases have been active, thus ensuring a 
sequential activation of mitotic events by Plk1.  Together with the polo-box domain 
mediated localisation of this  kinase to distinct scaffolds, the function of Plk1 at 
discrete mitotic events is both temporally and spatially regulated.   
In addition to the phosphorylation dependent regulation by the polo-box 
domain, Plk1 is activated by phosphorylation of the T-loop within the catalytic 
domain.  This phosphorylation of a conserved threonine at position 210 in human 
Plk1 is essential for the tertiary structure of the kinase domain and can be mimicked 
by a mutation to aspartate, resulting in a constitutive activation (Qian et al., 1999; Lee 
and Erikson, 1997).  In Xenopus, Plk kinase-1 and PKA have been identified as two 
candidate upstream activatory kinases (Qian et al., 1998; Kelm et al., 2002) but it is 
possible that other kinases are involved in activating Plk1.  In contrast, activatory 
phosphorylation events are antagonised by the removal of  human Plk1 from the cell 
by degradation (Barr et al., 2004).  Degradation of Plk1 is relies on a destruction motif 
present in the linker region between the catalytic and regulatory domains, whereas the 
degradation mechanism depends on the anaphase-promoting complex/cyclosome 
APC/C that works together with the cofactors Cdc20 and Cdh1 (Lindon and Pines, 
2004). 
The passage of Plk1 from centrosomes to kinetochores and spindles points to a 
function of this kinase in relation to these structures.  As previously mentioned, 
inactivation of Plk1 leads to the formation of aberrant monopolar spindles and a 
failure to recruit several proteins to the centrosome (Lane and Nigg, 1996; Gonzalez 
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et al., 1998; Donaldson et al., 2001).  An important protein that fails to be enriched 
during centrosome maturation at the G2/M boundary when Plk1 function is impaired 
is γ-tubulin, essential for microtubule formation and proper spindle formation (Lane 
and Nigg, 1996). Moreover, a substrate of Plk1 at the centrosome, Nlp, interacts with 
γ-tubulin ring complexes (Casenghi et al., 2003).  Nlp is phosphorylated by Plk1 at 
the beginning of mitosis and dissociates from the centrosome (Casenghi et al., 2005), 
probably allowing other γ-tubulin complex binding proteins to carry out their function 
during spindle formation.  Additionally, several other potential Plk1 substrates are 
implicated in microtubule dynamics and reside at the centrosome (Barr et al., 2004), 
such as the microtubule severing protein Katanin (McNally et al., 2002). 
The localisation of Plk1 at the centrosome gives it a ‘pole position’ to regulate 
the entry of mitosis.  Evidence indicates that activation of the Cdk1-cyclin-B complex 
begins at the centrosome and depends on dephosphorylation of Cdk1 (Jackman et al., 
2003) by Cdc25.  This phosphatase in turn is activated by Plx1 in Xenopus egg 
extracts, and is bound by Plk1 via the polo-box domain in a phosphorylation-
dependent manner (Kumagai and Dunphy, 1996; Elia et al., 2003a).  Plk1 is also able 
to phosphorylate Myt1, the kinase antagonistic to Cdc25 activity (Nakajima et al., 
2003).  Finally, cyclin-B1 itself is a substrate of Plk1 (Jackman et al., 2003) but the 
consequences of this phosphorylation remain unclear.  In summary, it seems that Plk1 
may be involved in the initiation of the cdk1-cyclin B phosphorylation cascade at the 
centrosome. 
Evidence suggests Plk1 and its homologues are involved in the regulation of the 
APC/C during mitosis and the onset of anaphase (Shirayama et al., 1998).  This 
regulation is achieved by directly phosphorylating several of the APC/C components, 
or by indirectly influencing this complex through proteins such as Xerp1 (Rauh et al., 
2005). Plk1 is also involved in sister chromatid cohesion, by phosphorylating and 
thereby activating the cleavage of cohesin subunits (Alexandru et al., 2001);(Sumara 
et al., 2002; Hauf et al., 2005) reviewed in (Watanabe, 2005).  It is likely that Plk1 is 
recruited to kinetochores in close proximity to these substrates, similar to the 
localisation of Plk1 to the centrosome during G2/M.   
Finally, towards the end of mitosis, Plk1 passes to the central spindle and is 
therefore appropriately positioned for its role in cytokinesis (van Vugt and Medema, 
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2005; Neef et al., 2006).  Plk1 substrates at this stage include Mklp1 and Mklp2 (Lee 
et al., 1995; Neef et al., 2003). 
Plk2  
Plk2 was first identified as an early response gene upon mitogenic stimulation of cells 
with serum or with phorbol ester, (Simmons et al., 1992) and is structurally similar to 
Plk1.  Analysis of protein stability revealed that Plk2 has a short half-time life during 
G1 and remains catalytically active during this stage of the cell cycle (Ma et al., 
2003).   
Several functions have been proposed for Plk2.  In an siRNA screen for 
regulators of apoptosis and chemoresistence, a lack of Plk2 in cells treated with low 
doses of taxol correlated with increased levels of apoptosis (MacKeigan et al., 2005) 
suggesting that Plk2 may be necessary for stress response pathways.  Similarly, Plk2 
was identified as a transcriptional target of p53 by microarray analysis  of diverse 
wild type and p53-null organisms, and silencing of Plk2 in tumour cells increased 
their sensitivity to microtubule destabilising and DNA damaging agents (Burns et al., 
2003).  Curiously,  Plk2-null mice are viable indicating that this kinase is not essential 
for development or post-natal growth (Ma et al., 2003).  Some retardation of growth 
and skeletal development was observed in these mice, and Plk2-/- embryo fibroblasts 
exhibited reduced proliferation and delayed entry into S-phase.  Plk2 has therefore 
been proposed to play a dual role; involvement in stress response pathways and 
regulating cell cycle exit from G1 (Winkles and Alberts, 2005).   
Plk2 may have other functions independent of the cell cycle.  Plk2 was found to 
interact with the calcium-integrin binding protein CIB (Ma et al., 2003) and its gene 
transcripts increase after nerve cells are chemically stimulated (Kauselmann et al., 
1999).  In another study, Plk2 (and Plk3) was induced in neurones by synaptic activity 
(Pak and Sheng, 2003).  Taken together, these data point to tissue specific functions 
for Plk2.   
Most pertinently to this thesis, Plk2 has been described to play a role in 
mammalian centriole duplication (Warnke et al., 2004).  When wt Plk2 was 
overexpressed in cultured cells, centrosome overduplication was observed.  
Conversely, overexpression of the catalytically inactive mutant, or depletion of the 
endogenous kinase by siRNA suppressed centrosome reduplication in S-phase 
arrested U2OS cells.  It has therefore been proposed that Plk2 is an essential regulator 
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of centriole duplication (Warnke et al., 2004).  However, it is difficult to reconcile 
these results with the finding that Plk2-/- mice are viable and only show minor defects 
in skeletal growth.  Plk2 is therefore appears to be redundant in the whole organism, 
whereas it is essential in cultured mammalian cells.  Clearly, Plk2 requires further 
research to elucidate its function as the centrosome.   
Plk3 
The third member of the polo-like kinase family is structurally similar to both Plk1 
and 2 (Figure 5), and was originally identified as a fibroblast growth factor-inducible 
early response gene in NIH-3T3 cells (Donohue et al., 1995).  Most confusingly, a 
whole plethora of functions have been ascribed to Plk3 in mammalian cells (Barr et 
al., 2004).  Reports suggest an involvement in the response to DNA damage (Xie et 
al., 2002b; Bahassi et al., 2002), in the regulation of Cdc25C and mitotic entry 
(Bahassi et al., 2004), putatively via p53 (Xie et al., 2001a; Xie et al., 2001b) and 
chk2 (Xie et al., 2002a).  Overexpression of Plk3 has been reported to inhibit 
cytokinesis (Conn et al., 2000) whereas microinjection of Plk3 transcripts into 
Xenopus oocytes resulted in accelerated maturation (Duncan et al., 2001).  
Furthermore, data indicates that Plk3 may have functions not related to the cell cycle.  
Plk3 interacts with Calcium-integrin-binding protein and may function in cell 
adhesion (Holtrich et al., 2000), synaptic plasticity and neuronal remodelling in 
mouse nerve cells (Kauselmann et al., 1999; Pak and Sheng, 2003).  Finally, 
endogenous Plk3 has also been found at both the centrosome and the Golgi apparatus 
(Ruan et al., 2004; Jiang et al., 2006), and overexpression led to morphological 
changes in cells by affecting microtubules (Wang et al., 2002).  In summary, much of 
the data on Plk3 appears contradictory and the function of this kinase in the cell 
remains unclear.   
Plk4 
Mouse Plk4 was first identified serendipitously in a screen to search for proteins 
regulating sialylation in mammalian cells using a murine cDNA library (Fode et al., 
1994).  The cDNA of the human homologue was separately isolated by a PCR-based 
search for novel kinases involved in cancer development (Karn et al., 1997).  Both 
approaches yielded the primary sequence data  and revealed that Plk4 is the 
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structurally most divergent member of the polo-like kinase family.  However, neither 
of these studies provided any insights into the function of this kinase.   
The Plk4 gene is located on chromosome 4q28 in humans and on chromosome 3 
in mice (Hammond et al., 1999; Swallow et al., 2005).  This region has been 
implicated in frequent rearrangements and loss in human tumour cells, particularly in 
hepatocellular carcinomas (Hammond et al., 1999).  The murine Plk4 gene has been 
reported to consist of 15 exons stretching over 16 kb of genomic sequence (Hudson et 
al., 2000).  Interestingly, in mouse two alternative spice variants are detectable and 
which differ in transcript length.  The full length Sak-a transcript encodes all 15 exons 
whereas the shorter and rarer Sak-b transcript is derived from early termination and 
alternative splicing at exons 5 and 6 (Hudson et al., 2000).  Sak-b is truncated and 
only comprises the complete kinase domain and a short C-terminal end, the latter 
encoded in 147 bp of exon 5.  In human Plk4, a 102 bp sequence insertion results in 
the addition of 34 amino acids and in the production of a longer peptide of 970 
residues, as opposed to the shorter mouse protein of 925 residues (Figure 5, (Hudson 
et al., 2000).  However, the human equivalent of a truncated Sak-b isoform has not 
been found and only one major transcript corresponding to the full length protein is 
known for human Plk4  
Like other polo-like kinase family members, the kinase domain of Plk4 resides 
in the N-terminus of the protein and spans residues 1 to 265 (Figure 5).  The kinase 
domain is most closely related to those of other Plk-family members, in particular to 
Plk2 (Fode et al., 1994), and shares common ancestry with other serine/threonine 
kinases.  However, unlike other Plk-family members, the kinase domain of Plk4 is 
followed by an extensive C-terminal region of >500 amino acids (Figure 5) and a 
single polo-box domain at the far C-terminal end.  The Plk4 polo-box domain itself is 
equally related to both polo-box domains 1 and 2 of the canonical double fold of Plk1 
(Fode et al., 1994) and, together with the loosely defined cryptic polo-box, was 
described to act as a dimerisation domain (Leung et al., 2002).  The polo-box and the 
PEST sequences (mentioned below) aside, the purpose of the large remainder of the 
C-terminal region is completely mysterious as it shares no sequence homology to any 
known protein, has not been solved structurally nor have any functions been assigned 
to it.   
X-ray crystallographic analyses of the polo-box domain structure of both Plk1 
and 4 have revealed organisational differences despite apparently similar secondary 
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structures (Leung et al., 2002; Elia et al., 2003b; Cheng et al., 2003).  Both are formed 
of six β-sheets and one α-helix when considered in isolation, yet form different 
overall structures.  The Plk4 polo-box exists as a homodimer when crystallised, with a 
shared anti-parallel sheet being formed from β-strands from both subunits (Leung et 
al., 2002).  Similarly, the Plk1- polo box domain forms a dimer when crystallised but 
achieves this intramolecularly from both sister polo-box domains (Elia et al., 2003b; 
Cheng et al., 2003).  This difference affects which residues are placed in the structure, 
such that the Plk4 polo-box dimer structure contains internal amino acids that are 
located externally on the Plk1 polo-box.  Furthermore, the Plk4 cleft was found to be 
shallower and broadened when compared to the Plk1 structure, and also lacks a clear 
positive charge on the surface.  Additionally, residues directly responsible for the 
phospho-peptide binding function of the Plk1 polo-box are not conserved in the Plk4 
primary sequence, suggesting that this functionality is not conserved (Figure 8).   
Indeed, no reports on a phospho-peptide binding ability of the Plk4 polo-box have 
been published up to the present.   
The cryptic-polo-box has been reported to contain some similarity to the Plk4 
polo-box domain itself (Leung et al., 2002), and functions as a homo-dimerisation 
domain.  In mouse Plk4, it is located upstream and adjacent to the actual polo-box 
domain (Figure 5).  When overexpressed, this domain has been reported to localise to 
the centrosome , nucleolus and the cleavage furrow (Hudson et al., 2001).  The Plk4 
cryptic-polo-box in conjunction with the polo-box domain could therefore form a 
structure that spatially regulates this kinase by binding to interaction partners or to 
putative phospho-peptides.  Reports of two interactors, the Tec kinase and p53 
(Yamashita et al., 2001; Swallow et al., 2005), which respectively bind to the cryptic- 
and the actual polo-box, could provide upstream inputs to the activity and localisation 
of Plk4 and thus reveal the existence of a regulatory mechanism as described for Plk1.  
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Three putative PEST motifs have been identified by sequence comparisons in 
the C-terminal region of Plk4, and are thought to be responsible for the short half-life 
of 2-3 hours of this kinase in asynchronous cells (Fode et al., 1996).  One PEST motif 
is located proximal to the kinase domain whereas the other two are further 
downstream near the polo-box domain.  Evidence supports the functionality of these 
PEST sequences in Plk4 turnover since deletion of these motifs increased the stability 
of overexpressed Plk4 (Yamashita et al., 2001).  Furthermore, the involvement of 
ubiquitination and the anaphase-promoting complex (APC/C) in regulating ectopic 
Plk4 has been reported (Fode et al., 1996) and may indeed suggest a regulatory role 
for degradation in controlling Plk4 activity, similar in this aspect to Plk1 (Lindon and 
Pines, 2004).   
Plk4 expression 
Reports indicate that Plk4 is cell-cycle regulated at the transcript level in patterns 
comparable to other Plk family members (Fode et al., 1996).  Studies using cultured 
cells and Northern blot analysis revealed that Plk4 mRNA is low in quiescent cells at 
G0 and early G1 (Fode et al., 1996).  Transcript levels increase from late G1 through 
to S and G2, and reach a plateau in M phase.  Likewise, when mice are subjected to 
partial hepatectomy, Plk4 transcripts in regenerating liver tissue increase from late G1 
to S phase, reaching their highest level during G2/M (Ko et al., 2005).  However, 
whether Plk4 is regulated through levels of mRNA, protein or catalytic activity is 
currently not known.   
Similarly, Plk4 expression levels in adult tissues have only been analysed by 
Northern blotting (Fode et al., 1994; Karn et al., 1997).  Plk4 transcripts were found in 
murine testis, thymus and spleen but were not detectable in brain, heart, kidney, liver 
or ovary tissue samples (Fode et al., 1994).  In another study using human tissues, 
highest levels of Plk4 mRNA were found in thymus and testis (Karn et al., 1997), 
suggesting that tissues with actively dividing cells may contain the highest amounts of 
Plk4.  This notion is supported by in situ hybridisation studies on whole sections of 
mouse embryos at various stages, which show that Plk4 mRNA is at first evenly 
distributed, but is then restricted to zones of proliferating cells (Fode et al., 1994).  
Conversely, overexpression of a Plk4 antisense fragment suppressed proliferation of 
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transfected CHO cells (Fode et al., 1994).  Furthermore, a study on the levels of Plk4 
in samples of colorectal cancer (Macmillan et al., 2001) revealed elevated levels of 
Plk4 in tumour tissue when compared to adjacent normal intestinal cells.  The 
fragmentary evidence thus points to a possible link between Plk4 and cell 
proliferation.   
Data on the Plk4 protein itself remains scarce.  Overexpression studies using 
mouse epitope tagged Plk4 transfected into cells (Hudson et al., 2000) has placed this 
kinase in the nucleolus during G2, at the centrosomes at G2/M, to the cleavage furrow 
during cytokinesis and to the perinuclear region at G1.  Deletion of the polo-box 
domain resulted in a mislocalisation of the overexpressed protein to the cytoplasm in 
all stages of the cell cycle.  In a subsequent study, a fragment comprising the polo-box 
domain tagged with GFP was located at the centrosome and the cleavage furrow in 
cultured mammalian cells (Leung et al., 2002).  Somewhat in contradiction to the 
earlier data, a Plk4 deletion mutant lacking the polo-box domain was still 
centrosomal.  In summary, the above immunofluorescence data allows speculation on 
the involvement on Plk4 in diverse cellular processes such as in centrosome biology 
or cytokinesis.  However, prior to the work described in this thesis, nothing was 
known about the localisation of the endogenous protein. 
 
Plk4 knock-out mice 
Hints as to the importance of Plk4 in cell proliferation have been gained from mouse 
knockout experiments (Hudson et al., 2001; Ko et al., 2005).  Plk4-/- mouse embryos 
arrest shortly after gastrulation, with an increase in mitotic cells containing partially 
segregated chromosomes.  Explants from these embryos also arrest in anaphase and 
telophase after a few cell divisions, with a concomitant 20 fold increase in apoptotic 
cells and consequently the cellular phenotype of these embryos has been described as 
a late mitotic delay (Hudson et al., 2001).  A possible explanation for these 
observations is that Plk4 is partially redundant for cell division until gastrulation, 
since embryos are able to divide initially (Swallow et al., 2005; Hudson et al., 2001).  
Alternatively, Plk4 is supplied maternally and initial cell divisions run on pre-existing 
cellular stores of this kinase until they are depleted when gastrulation begins.  Never-
the-less, the lethality of Plk4 deficiency reveals that this unusual Polo-like kinase is 
 33
 
essential to the development of a complete organism, and stands in stark contrast to 
the viability of Plk2-/- mice.   
Analysis of Plk4+/-  mice has revealed a potential role for Plk4 in tumorigenesis 
(Ko et al., 2005).  These mice grow normally to adulthood, but develop tumours over 
time, most notably in lung and liver tissue.  When Plk4+/- mice were subjected to a  
partial hepatectomy to stimulate growth of tissue, increased numbers of liver cells 
with aberrant multipolar spindles were observed.  Regenerating liver tissue showed 
altered regulation of cyclins D, E and B and reduced levels of p53 and p21, suggesting 
that cells are subject to a cell cycle delay.  In particular, levels of cyclin B were 
flattened and extended during prolonged mitosis.  Similarly, Plk4+/-  MEFs displayed 
increased numbers of centrosomes, abnormal spindles as well as slower growth.  
Taken together, these data suggest that Plk4 haploinsufficiency results in abnormal 
mitotic progression and carcinogenesis.  
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AIMS OF THIS PROJECT 
 
Early studies on Plk4 have uncovered a possible role of this kinase in cell 
proliferation and centrosome biology (Fode et al., 1994; Fode et al., 1996; Hudson et 
al., 2001; Leung et al., 2002).  Moreover, the Plk4-/- mouse knockout is embryonic 
lethal, pointing to a non-redundant function of this Plk family member in cell division 
and early development (Hudson et al., 2001).  Despite these initial reports, very little 
was known about the endogenous kinase and the precise function of this structurally 
divergent Plk-family member remained unclear. Therefore, the aim of this study was 
to characterise the function and regulation of human Plk4 in mammalian cells. 
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RESULTS 
Sequence analysis of Plk4 
Plk4 was discovered serendipitously in a screen for sialylated proteins, and by virtue 
of its homology to other polo-like kinases (Fode et al., 1994; Karn et al., 1997).  
These studies highlighted the presence of an N-terminal kinase domain and a C-
terminal domain containing a polo-box motif which has been structurally solved by 
X-ray crystallography (Leung et al., 2002).  However, very little detail has been 
obtained on the structure of the extensive linker region connecting these two easily 
identifiable domains.  Simple predictive programs were therefore used to uncover 
potential motifs or secondary structures in this uncharacterised region of Plk4.   
A motif scan of human Plk4 (ScanProsite, www.expasy.ch, not shown) 
confirmed the presence of an N-terminal dual specificity kinase domain, stretching 
from residues 12-265, and which is predicted to phosphorylate both serine/threonine 
and tyrosine residues.  Whether the catalytic domain of Plk4 favours one or the other 
set of residues is at present unclear as no consensus substrate motifs have been 
reported.  Additionally, the polo-box was identified at the far C-terminus, consistent 
with previous reports  (Leung et al., 2002).  However, no known domains were found 
in the linker region located between the catalytic and polo-box domains. 
Scanning the primary sequence of Plk4 with a secondary structure prediction 
program (PsiPred, www.expasy.ch) revealed the presence of numerous α-helices 
upstream of the polo-box domain, in addition to some β-sheet structures (Figure 9).  
Whilst secondary structure programs are inherently limited in providing structural 
information, the program used here predicts five β-sheets and one α-helix for the 
region where the polo-box domain is found.  This result recapitulates the reported 
crystal structure of the Plk4 polo-box  (Leung et al., 2002) and, similarly, the extent of 
the kinase domain is faithfully reproduced.  Interestingly, the previously 
uncharacterised linker now features numerous predicted secondary structures 
spanning the residues 610-810 upstream of the polo-box.  These consist of several β-
sheet structures interspersed with three α-helical domains which lie downstream of a 
predicted linker structure comprising approximately 350 residues.  These structures 
most likely form part of the loosely defined cryptic polo-box and were not identified 
in the motif scan, thus representing novel domains if physiologically relevant in vivo.   
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Figure 9. Plk4 contains additional structures outside of the kinase and polo-box domains. The 
peptide sequence of Plk4 was submitted to the PsiPred server (www.expasy.ch, (McGuffin et al., 
2001).  Predicted α-helices are depicted in green and β-sheet structures in yellow.  The confidence of 
prediction is graphically represented in blue.   
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Numerous centrosomal proteins with structural roles such as AKAP450 or 
PCM-1 (Keryer et al., 2003b; Balczon et al., 1994) contain extensive coiled-coil 
regions.  To reveal whether any of the predicted secondary structures form putative 
coiled-coil domains, the COILS program was used to scan the peptide sequence of 
Plk4 (COILS at www.expasy.ch; (Lupas et al., 1991).  As seen in Figure 10, a short 
stretch located across residues 750-800 was predicted as a coiled-coil structure at 
significant values (Lupas et al., 1991).  This putative coiled-coil domain coincides 
with an α-helical structure predicted by the previous secondary structure program and 
may therefore point out a domain important for a structural role of the C-terminus of 
Plk4.  Whether the function of Plk4 depends on the presence of a coiled-coil structure 
is at present unclear.  
In addition to the easily identified kinase and polo-box domains, Plk4 therefore 
contains several unknown domains that are revealed by secondary structure prediction 
programs.  These domains are located upstream of the polo-box and consist of both β-
sheets and α-helices, one of which is predicted to form a coiled-coil domain.  If these 
structures exist in vivo, they could represent previously uncharacterised novel 
domains and thus deserve further investigation.   
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Figure 10. Plk4 contains a predicted coiled-coil domain.   The primary sequence of Plk4 was 
analysed by the COILS program (www.expasy.ch,(Lupas et al., 1991).  One short region of Plk4 
(approximately residues 750-800) showed a significant prediction above a threshold value (>0.5).   
 
Plk4 homologues identified in other organisms 
The existence of several Plk4 orthologues in other organisms has been shown (Fode 
1994, Karn 1994, Leung et al 2001).  In particular, a report mentioned Plk4 
homologues in Zebrafish (Danio rerio), Drosophila, and rat (Rattus norvegicus), thus 
pointing to a conservation of this kinase in both vertebrates and invertebrates (Leung 
et al., 2002).  However, few details on the degree of homology between related Plk4 
proteins has been published.  
A standard protein BLAST search was performed to uncover additional Plk4 
homologues in other organisms (Altschul et al., 1990).  When the human Plk4 protein 
sequence was submitted to the NCBI BLAST server and non-redundant protein 
databases were searched, several previously unreported homologues were found 
(summarised in Table 2 and Figure 11).  Homologues were found in a range of both 
vertebrates and non-vertebrates, but no obvious fungal or plant Plk4 proteins were 
detected.  Predictably, the closest homologues to human Plk4 were found in primates, 
followed by other mammals such as mouse, rat, cow and dog which overall showed 
more than 80% residue identity.  However, despite this high degree of relatedness, 
some variability was found in the length of the Plk4 protein itself.  For example, 
whereas the mouse Plk4 reference sequence comprises 925 residues, the rat Plk4 is 
1247 amino acids long and contains N- and C-terminal sequences not found in human 
Plk4 (Figure 11).  A motif scan of the rat N-terminal 200 residues did not find any 
known domains, and a BLAST-search did not detect any obvious homologues.  The 
relevance of these rat sequences not found in the human Plk4 is unknown.   
Plk4 homologues with 40-60% identity were found in fish species, Xenopus and 
chicken (Table 2).  As with mammalian Plk4 homologues, all contained the kinase 
and the polo-box domains, with the exception of zebrafish for which only a partial 
sequence was available in the protein database.  Similarly well conserved homologues 
were detected in  five insect species, of which Drosophila Plk4 had been reported 
previously.  Interestingly, all insect Plk4 proteins contain a central linker region that is 
not conserved in vertebrate Plk4s (Figure 11), an evolutionary development thus 
peculiar to this phylum.   
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identity similarity
residues 
with Plk4 
homology 
homology 
to Plk4 
region 
length 
of 
protein Accession 
       
Macaca fascicularis 96% 98% 1-575 396-970 575 BAE02419 
Pongo pygmaeus 97% 98% 1-970 1-970 970 CAH91413 
Chimpanzee (Pan 
troglodytes) 96% 97% 144-1094 3-970 1094 XP_517431 
Dog (Canis familiaris) 88% 93% 49-1016 1-969 1017 XP_533295 
Cow (Bos taurus) 87% 92% 58-1015 9-970 980 XP_592250 
Rat (Rattus 
norvegicus) 79% 87% 200-1145 11-969 1247 XP_227064 
Mouse (Mus 
musculus) 78% 86% 1-924 1-969 925 NP_035625
Chicken (Gallus 
gallus) 66% 79% 70-1026 9-966 1029 XP_420462 
Xenopus laevis 59% 72% 1-940 1-964 944 AAH60363 
Pufferfish (Tetraodon 
nigroviridis) 50% 64% 1-919 9-965 920 CAG10565 
Zebrafish (Danio rerio) 42% 57% 1-707 230-965 711 AAH45434 
Purple sea urchin 
(Strongylocentrotus 
purpuratus) 38% 54% 57-1092 7-955 1323 XP_793779 
Honey Bee 63% 78% 9-289 6-286 754 XP_623133 
(Apis mellifera) 38% 53% 403-748 592-965   
Red Flour Beetle) 62% 81% 1-261 5-267 720 XP_974451 
(Tribolium castaneum 33% 50% 387-718 594-968   
Drosophila 
pseudoobscura 59% 82% 8-270 6-267 777 EAL29859 
 34% 53% 382-736 588-952   
Fruit fly (Drosophila 
melanogaster) 57% 78% 8-291 6-268 769 AAF51737 
 33% 53% 388-735 593-960   
Anopheles gambiae 58% 75% 1-279 11-286 496 EAA02947 
 39% 65% 361-496 598-730   
C. elegans 26% 44% 7-351 6-371 706 Q9GT24 
       
 
 
Table 2. Homologues of Plk4.  Plk4 was submitted to the BLAST server as NCBI 
(www.ncbi.nlm.nih.gov (Altschul et al., 1990).  Identity defines conserved residues whereas similarity 
refers to exchange of amino acids of similar properties.   The regions of homology to human Plk4 are 
given together with the cognate residues in the human kinase.   
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Figure 11. Plk4 homologues.  Schematic representation of representative homologues of human Plk4 
showing conserved domains, based on a BLAST search of a non-redundant protein database.  The C. 
elegans sequence was aligned by pairwise-BLAST.  Residues with significant homology are drawn as 
boxes, unrelated sequences as black lines.  Kinase domains are in red, polo-boxes in green, linker 
regions are left white.  Mutations introduced into the human Plk4 kinase domain are shown.  Minor 
alignment gaps were omitted for clarity.  Hs: human Plk4, Pt: Pan troglodytes, Rn: Rattus norvegicus, 
Mm: Mus musculus, Xl: Xenopus laevis, Dr: Danio rerio, Sp: Strongylocentrotus purpuratus, Dm: 
Drosophila melanogaster, Ce: Caenorabditis elegans.  The asterisk denotes an incomplete Zebrafish 
sequence.  Scale bar: 100 residues.   
 
Curiously, this BLAST search also picked up a putative kinase from purple sea 
urchin (Strongylocentrotus purpuratus, Figure 11).  This kinase has overall homology 
to Plk4, but contains an additional polo-box domain in the far C-terminus that is 
otherwise unrelated to any human Plk4 sequence.  The presence of two polo-boxes 
would mark this kinase as an homologue of Plks 1, 2 or 3.  However, the polo-boxes 
contained within this kinase resemble canonical Plk4 polo box motifs in their lack of 
conserved residues required for binding to phosphopeptides, generally found in other 
Plk-family members.  Moreover, this kinase contains a large uncharacterised central 
region and widely spaced polo boxes, both features untypical of Plk1.  Whether this 
sea urchin Polo-like kinase is a genuine homologue of Plk4 is however open to 
speculation.   
Plk4 is not significantly related to Zyg-1 
The Zyg-1 kinase has been identified as essential for centriole duplication in C. 
elegans (O'Connell et al., 2001).  We hypothesised that Plk4 may regulate mammalian 
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centriole duplication and therefore asked whether this kinase is the closest human 
homologue of Zyg-1.  H. Lutz and M. Vingron (Max-Planck-Institute for Molecular 
Genetics, Berlin) generously performed detailed comparative sequence analyses with 
Zyg-1 and Plk4, and a summary of their findings is recounted here.   
The Zyg-1 kinase has an N-terminal catalytic domain, but otherwise no other 
domains are detected.  A simple BLAST search of the kinase domain revealed a 
serine/threonine kinase in Plasmodium falciparum as the closest non-nematode 
homologue in addition to other related proteins including serine-threonine kinases in 
plants and several more distantly related vertebrate kinases.  Among these various 
protein kinases, NimA related kinases and the polo-like kinase were found.  However, 
when complete genome databases were searched for orthologues of Zyg-1 using 
tBLASTx, only one orthologue in the related nematode Caenorhabditis briggsae was 
detected.  No obvious mammalian homologues were found using these methods.   
When a PSI-BLAST search with three iterations was used to detect remote 
homologues of Zyg-1, multiple proteins were found that are related to the Zyg-1 C-
terminus.  Among these, the putative chicken Plk4 homologue was found, suggesting 
that a Plk4 homologue was indeed a related kinase.  Unfortunately, no polo-box 
related sequences were found when Zyg-1 was aligned with the polo-box motif using 
the program Hmmalign.  Furthermore, no RCC repeats typical of the NimA related 
kinase Nek8 (reviewed in (O'Connell et al., 2003) were found when Zyg-1 was 
scanned using Prosite (www.expasy.org/prosite), nor were any repeated structures 
detected.  Homology of Zyg-1 to Plk4 therefore appears limited to N-terminal 
catalytic domains.   
To clarify whether Plk-family members or NimA related kinases were more 
closely related to Zyg-1, a phylogenetic tree was assembled.  A representative 
selection of 56 homologues from the Polo-like kinases, the Aurora/Ipl related kinases  
and the NimA related kinases in addition to the Zyg-1 kinases were included in this 
analysis.  Tree construction was based on a multiple alignment of protein kinase 
domains only since the homology amongst these kinases was confined to this 
particular domain (Figure 12).  The phylogenetic tree revealed that the two nematode 
Zyg-1 kinases were equally distant to Polo-like kinases and NimA related kinases.  
The hypothesis that Plk4 is the closest homologue of Zyg-1 was therefore not 
supported by these results.   
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Figure 12. Phyolgenetic tree showing the relationship of Zyg-1 to Plks, Aurora- and NimA related 
kinases (Lutz & Vingron).  Homology among sequences was restricted to the shared kinase domain.  
Tree assembly was based on an alignment of 56 sequences of 270 residues in length using the protein 
kinase HMM profile and the hmmalign program.    Zyg-1 kinases are highlighted in blue and Plk4 
homologues in yellow.  The outgroup sequence Q9MA08 of an unrelated plant protein was used.  
Evolutionary distances were calculated by bootstrapping.  B: C. Briggsae, C: C. elegans, D: D. 
melanogaster, H: H. sapiens, M: M. musculus.  Note that the two Zyg-1 proteins group separately, and 
are equally distant from either NimA related kinases or Plks. 
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Recombinant human Plk4 is an active kinase 
As an initial approach to the characterisation of Plk4 and its function in mammalian 
cells, the catalytic activity of Plk4 was investigated.  The cDNA of Plk4 was obtained 
by purchasing an EST clone (AI561146) from the Image Consortium.  After complete 
sequencing, this EST clone was found to contain the whole Plk4 coding sequence and 
additional 3´- and 5´- untranslated regions (UTRs).  The Plk4 cDNA was subcloned 
into suitable mammalian and bacterial expression vectors, discarding UTRs in the 
process.  As a control, residues located in the kinase domain that are critical for 
enzymatic activity were mutated (K41R, D154A, Figure 11) to generate catalytically 
inactive (dead) kinase.  Moreover, a regulatory threonine residue that is usually 
phosphorylated for full catalytic activity was mutated to an aspartate (T170D) in an 
attempt to generate a constitutively active kinase. 
Bacterial expression and purification of 6xHis-, GST- and maltose binding 
protein-tagged full length Plk4 was attempted to obtain soluble and active kinase.  
Unfortunately, tagged Plk4 fusions were either not expressed, or in the case of the 
maltose binding protein-Plk4 fusion protein, were completely insoluble (not shown).  
Similarly, 6xHis-tagged Plk4 from recombinant baculovirus infected Sf9 insect cells 
was also insoluble.  Therefore, the only available method to obtain soluble 
recombinant full length Plk4 was to transiently transfect HEK293T cells with 
mammalian expression vectors and to immunoprecipitate myc-tagged kinase from 
total cell extracts (Figure 13). 
 
 
Figure 13. Full length wt Plk4 is an active enzyme.   myc-tagged Plk4 was purified from 
overexpressing 293T cells, subjected to an in vitro phosphorylation assay, transferred to a 
nitrocellulose membrane and exposed to film. Left panel shows membrane probed with anti-myc 
antibody (IgG marked with an asterisk), right panel shows autoradiogram of kinase assay revealing 
autophosphorylation.  Note upshift of wt, but not T170D mutant kinase.   
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To assay catalytic activity, purified wt and mutant Plk4 were used for in vitro 
kinase assays in the presence of [γ-32P]ATP (Figure 13).  Proteins were separated by 
SDS-PAGE, transferred to nitrocellulose membrane and exposed to film.  Equal 
loading of wt and dead Plk4 was assayed by Western blot analysis using the same 
membrane.  Unfortunately, when the commonly used exogenous substrates casein, 
myelin-basic protein, histone 1 and 3 were screened for suitability, no 
phosphorylation by Plk4 above background was detected in parallel kinase assays (not 
shown).  As seen in Figure 13, the activity of wt Plk4 was therefore only detected by 
auto-phosphorylation, whereas dead Plk4 exhibited no signal.  The wt kinase also 
showed some retarded electrophoretic mobility when compared to dead kinase, 
suggesting that phosphorylation was responsible for this characteristic.  Surprisingly, 
although the T170D mutant was active, no upshift was detected.  The phosphorylation 
of this particular threonine residue in the wt kinase may therefore be responsible for 
the retarded electrophoretic mobility of Plk4.   
In an alternative approach, the GST-tagged kinase domain of Plk4 (residues 1-
265) was bacterially expressed and purified.  In contrast to full length Plk4, the kinase 
domain was readily expressed and also soluble, thus permitting the isolation of 
significant amounts of enzyme for further work.  The recombinant Plk4 kinase 
domain was then used in kinase assays together with substrates in the presence of [γ-
32P]-ATP, and separated by SDS-PAGE.  As seen in Figure 14, recombinant Plk4(1-
265) readily phosphorylated the exogenous substrate casein and also showed 
prominent auto-phosphorylation, whereas catalytically inactive D154A-Plk4(1-265) 
used as control did not.   This therefore confirms the specificity of the reaction.  
Furthermore, the β-subunit of casein was preferentially phosphorylated in contrast to 
Plk1 which phosphorylates the α-subunit (Golsteyn et al., 1995).  This suggests that 
Plk4 favours different substrate motifs.  Finally, autophosphorylation most likely 
accounted for the retarded electrophoretic mobility of Plk4(1-265) seen in Figure 14. 
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Figure 14. The kinase domain of Plk4 is an active enzyme.  Equal amounts of purified wt and dead 
GST-Plk4(1-265) were subjected to an in vitro kinase assay in the presence of [γ-32P]-ATP together 
with casein as substrate.  (a) Kinase reactions were then separated by SDS-PAGE and stained with 
Coommassie Blue.  Note retardation of wt Plk4(1-265).  (b) Autoradiogram of kinase assay showing 
autophosphorylation and phosphorylation of substrate.   
 
Taken together, these results demonstrate that Plk4 is an active protein kinase.  
In particular, autophosphorylation occurred on the kinase domain itself and was 
responsible for the retardation of electrophoretic mobility.  Furthermore, casein may 
be used as an exogenous substrate for the recombinant kinase domain but is of limited 
use for full length Plk4 isolated from cell extracts.   
 
Searching for interactors of Plk4 
Although interacting partners of Plk4 have been reported (Yamashita et al., 2001; 
Swallow et al., 2005), no physiologically relevant interactor has yet been described.  
However, Plk4 has been reported as a centrosomal kinase (Leung et al., 2002) and 
plausible interactors may themselves be centrosomal.  In an unbiased approach to find 
potential centrosomal binding partners, a human lymphocyte cDNA library was 
screened using yeast two-hybrid analysis.  Full length dead Plk4 fused to the GAL4 
DNA binding domain was used as bait and cotransformed with vectors containing 
library cDNA.  Approximately 800,000 transformants were plated and screened, and a 
significant number of these were able to grow on selective drop-out medium.  The 
library plasmids of 30 positive clones were isolated and co-transformed with the bait 
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to confirm a positive interaction.  The plasmids scoring positive were sequenced 
(Table 3) but no known centrosomal components or immediately  obvious interactors 
were found.  Four plasmids were found to encode the protein MDS011 of unknown 
structure or function.  Of more interest, a Guanine nucleotide binding protein subunit 
was found in addition to a 14-3-3 protein isoform, known to bind phosphopeptides 
(Mhawech, 2005).   
 
 
Occurrence Accession  
4x AAG14960 MDS011 
 AAH14256 Guanine nucleotide binding protein (G protein), beta polypeptide 
 2C23_A Chain A, 14-3-3 Protein Beta (Human) 
 CAI23831 proto-oncogene tyrosine-protein kinase LCK 
2x AAH02323 ZYX protein, zyxin, actin cytoskeleton associated protein 
 NP_002994 SEC14 (S. cerevisiae)-like 1 isoform a [Homo sapiens] 
 CAH74116 glycine dehydrogenase 
 NP_009152 polyamine-modulated factor 1 
 NP_004387 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 
 NM_001005271 
CHD3 protein, chromodomain helicase DNA binding protein 3 
isoform 3 
 NP_699202 PDZ domain containing ring finger 1, interactor of Numb proteins 
 AAA99715 putative tumour suppressor H37 RNA binding motif protein 5 
 AAH30025 TIAL1 protein 
 AAH19265 PKM2 protein, pyruvate kinase 
 CAA71749 CAP-binding protein complex interacting protein 1 
 BAD96885 leupaxin variant 
2x BAD96249 
eukaryotic translation initiation factor 3 subunit 6 interacting protein 
variant 
 AAH13311 Mitochondrial ribosomal protein L38 
 NP_001025162 FLJ20859 protein isoform 1, predicted rRNA methylase 
   
 
 
Table 3. List of identified yeast two-hybrid interactors of full-length Plk4.  Full length Plk4 was 
used as bait to screen a human lymphocyte plasmid cDNA library.  Listed are positive clones whose 
interaction was confirmed by retransformation with bait into host yeast.  The number of each positive 
plasmid was one unless stated otherwise.   
 
 
To reduce the number of positive clones, a truncated N-terminal fragment of 
Plk4 consisting of the kinase domain and part of the linker was used to screen a 
similar number of transformants of the same cDNA library.  This screen resulted in a 
total of 11 positive interactors (Table 4).  Again, no known centrosomal components 
were found, however a G-protein subunit as well as a G protein pathway suppressor 
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protein was identified.  Furthermore, plasmids encoding an alpha-helical protein of 
mainly coiled-coil structure but of uncharacterised function were found in four 
positive clones.   
 
 
Occurrence Accession 
 NM_020482 FHL5 LIM protein Act 
 NM_015338 
ASXH1 human homologue of Dm 'additional sex-comb like 
1', polycomb group protein 
 NM_005648 Transcription elongation factor B 
4x AF216493 C6orf18 alpha-helical protein (HCR), mainly coiled-coil 
 BC013652 GPS2 G protein pathway suppressor 2 
 NM_031203 
hnRPM 
heterogeneous nuclear ribonucleoprotein M 
 BC029996 G protein beta-polypeptide-2 
 AF018034 ECE-1 endothelin converting enzyme-1  
    
 
 
Table 4. Yeast two-hybrid interactors of N-terminal Plk4.  A truncated Plk4 bait consisting of 
residues 1-380 was used to screen the same human lymphocyte library.  The number of each plasmid 
found was one unless stated otherwise.   
 
 
 
Due to the inconclusive results obtained by yeast two-hybrid screening, an 
alternative approach to finding interactors of Plk4 was sought.  A cell line that 
contains a stably integrated plasmid allowing inducible expression of Flag-tagged wt 
Plk4 under tetracycline control was used for immunoprecipitation of overexpressed 
kinase after 24 hours of induction.  Immunocomplexes were pulled down using anti-
Flag antibodies, competitively eluted with Flag peptide and separated by SDS-PAGE 
(Figure 15).  After staining with Coomassie Blue, bands were excised and analysed by 
mass-spectrometry, kindly performed by X. Li (Max-Planck Institute of Biochemistry, 
Martinsried).  Regions of unstained SDS-PAGE gel between prominently stained 
bands were also investigated since these were thought to contain low abundance 
proteins such as centrosomal components.   
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Figure 15. Mass-spectrometric analysis of Plk4 immunocomplexes.  Flag-tagged Plk4 
overexpressed in an inducible stable cell line was immunoprecipitated with anti-Flag antibodies and 
eluted with Flag-peptide.  After separation by SDS-PAGE and staining with Coomassie Blue, the bands 
and regions indicated were excised and analysed by mass-spectrometry (X. Li, Max-Planck Institute for 
Biochemistry, Martinsried).  
 
 
 
Using this approach, the known centrosomal component Ch-TOG was 
identified.  Notably, Ch-TOG is the mammalian homologue of XMAP215, both being 
microtubule binding factors required for proper bipolar spindle formation in Xenopus 
egg extracts (Ohkura et al., 2001; Cassimeris and Morabito, 2004).  Furthermore, the 
protein phosphatase 2C isoform β (PP2C-β, also known as PPM1B) was identified in 
this mass-spectrometric analysis of Plk4 immunocomplexes.  This protein 
phosphatase is expressed as multiple isoforms and is the founder member of a 
monomeric group of phosphatases insensitive to commonly known phosphatase 
inhibitors such as calyculin A.  Furthermore, PP2C-β has been implicated in the 
dephosphorylation of Cdks in mammalian cells, in particular Cdk2 (Kusuda et al., 
1998; Cheng et al., 1999; Cheng et al., 2000; Seroussi et al., 2001).  Revealingly, 
Drosophila mutant embryos defective for PP2C-β arrest early in development 
displaying a mitotic arrest, supernumerary centrosomes and defects  in microtubule 
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attachment to centromeres (Snaith et al., 1996).  PP2C-β may therefore act as the 
antagonistic protein phosphatase to Plk4. 
Due to the relevance of  PP2C-β, the cDNA of this phosphatase was acquired 
from the Image Consortium (BC064381) and subcloned into tagged mammalian 
expression vectors.  U2OS cells transfected with Flag- or myc-tagged PP2C-β showed 
a diffuse staining distributed throughout the cell cytoplasm when analysed by 
immunofluorescence microscopy, but no overexpressed protein was enriched at the 
centrosome (not shown).  Whether PP2C-β is therefore a cellular interactor of Plk4 
remains unclear.   
Taken together, the above results suggest that searching for Plk4 interactors 
using unbiased approaches is only moderately successful.  Yeast two-hybrid screens 
using Plk4 as bait did not uncover any obvious interactors.  Immunoprecipitation of 
overexpressed Plk4, however, allowed the identification of PP2C-β and Ch-TOG as 
two interesting candidate proteins, and further work will be required to confirm the 
physiological relevance of these proteins for the function of Plk4.   
 
Overexpressed Plk4 localises to centrosomes 
Previous reports have shown that overexpressed and GFP- tagged Plk4 localises to the 
centrosome, the perinuclear region, the nucleolus and the cleavage furrow in 
mammalian cells in a cell-cycle dependent manner (Hudson et al., 2001; Leung et al., 
2002).  U2OS cells were therefore transfected overnight with variously tagged Plk4 
mammalian expression constructs and examined by immunofluorescence microscopy.  
Centrosomes were visualised by staining with anti-C-Nap1 antibodies.  
As seen in Figure 16a, myc-tagged wt Plk4 localised to the centrosome but not 
to the nucleolus or perinuclear region in interphasic cells.  Tagging Plk4 with FLAG 
or GFP at N- or C-terminal ends did not alter the centrosomal localisation of this 
kinase. 
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Figure 16. Overexpressed Plk4 localises to the centrosome in mammalian cells.  (a) U2OS cells 
were transfected for 12 hours with myc-, Flag- or GFP-tagged wt Plk4 and prepared for 
immunofluorescence microscopy.  Overexpressed kinase was detected with anti-myc or anti-Flag 
antibodies or by GFP fluorescence (green), centrosomes were detected by C-Nap1 antibodies (red).  (b) 
Overexpressed myc-tagged dead (D154A) or T-loop mutant (T170D) Plk4 showed similar centrosomal 
staining.  (c) Cells transfected with myc-tagged wt Plk4 were left on ice for 30 minutes to depolymerise 
the microtubule network and analysed by immunofluorescence microscopy.  Insets show enlargements 
of the centrosome.  Scale bar: 10µm  
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Likewise, the centrosomal association of Plk4 was not dependent on catalytic activity 
because tagged versions of dead or T170D mutant kinase were also found at this 
organelle (Figure 16b).  Furthermore, the centrosomal localisation of Plk4 was 
maintained after cells were incubated on ice for 1 hour to depolymerise microtubules 
(Figure 16c).  This result indicates that Plk4 is stably associated with the centrosome, 
and is not involved in a dynamic recruitment process dependent on an intact 
microtubule network.  
In summary, these overexpression studies reveal that newly synthesised Plk4 is 
recruited to the centrosome independently of catalytic activity, of polymerised 
microtubles or the tag used.  Whilst the previously reported centrosomal localisation 
of overexpressed Plk4 could be confirmed, no staining of other cellular structures was 
observed.   
 
Endogenous Plk4 is a centrosomal kinase 
To explore the localization and function of endogenous human Plk4, a rabbit 
polyclonal antibody was raised using a bacterially expressed fragment of Plk4 as 
antigen.  The antigen consisted of the linker of Plk4, spanning residues 314 to 817 
(Figure 17a), and was chosen due to its lack of homology with other polo-like kinases.  
The affinity purified antibody did not recognise a band of the correct size in Western 
blot analyses of lysates of asynchronously growing human cells.  Since the antibody 
was unable to detect endogenous Plk4, U2OS cell lines expressing FLAG-tagged wild 
type and catalytically inactive (D154A) Plk4 under tetracycline control were 
established (Figure 17b).  When used for Western blot analysis of lysates prepared 
from this cell line, the antibody readily recognized a protein of the expected size in 
cells induced to express Plk4, but did not reveal any specific bands in non-induced 
cells suggesting that endogenous Plk4 is of low abundance (Figure 17b).  However, 
Western blot analysis confirmed the presence of endogenous Plk4 in purified 
centrosomes (Figure 17b). The antibody was also able to immunoprecipitate a protein 
of predicted size (Figure 17c). 
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Figure 17. Antibody characterisation.  (a) Schematic representation of Plk4, indicating the domain 
(residues 314-817) used for antibody production.  (b) Extracts from cell lines carrying an inducible 
human wt Plk4 cDNA and purified centrosomes were probed by Western blotting with anti-Plk4 
antibody.  (c)  Immunoprecipitation with purified anti-Plk4 antibody or non-immune rabbit IgG as 
control from equal amounts of total extracts prepared from asynchronous 293T cells.  
Immunocomplexes were probed with anti-Plk4 antibodies to detect kinase.   
 
 
Immunofluorescence staining of asynchronously growing U2OS cells showed 
that endogenous Plk4 associates with centrosomes throughout the cell cycle, as 
indicated by its co-localization with γ-tubulin (Figure 18a).  Similar results were 
obtained in HeLa and HCT116 cells (data not shown).  Pre-incubation of antibodies 
with antigen abolished centrosome staining (Figure 18b).  Interestingly, Plk4 staining 
of G1 phase cells generally revealed two closely spaced dots, whereas four dots could 
occasionally be seen in G2 phase cells.  Invariably, these dots co-localized with 
centrin, a marker for centrioles (Figure 18c), when HeLa cells stably expressing 
centrin-1-GFP (Piel et al., 2001) were stained with the anti-Plk4 antibody.  
Endogenous Plk4 therefore associates with centrioles throughout the cell cycle.  
However, in contrast to the reported localization of EGFP-tagged murine Plk4, 
endogenous human Plk4 was not observed to localise to either nucleoli or cleavage 
furrows.  In summary, these results thus confirm and  extend previous data on EGFP-
tagged murine Plk4 (Leung et al., 2002) and point to a role of this kinase in 
centrosome biology. 
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Figure 18. Endogenous localises to the centrosome throughout the cell cycle.  (a) U2OS cells were 
co-stained with anti-Plk4 (green) and anti-γ-tubulin (red) antibodies and analyzed by 
immunofluorescence microscopy; DNA was stained with DAPI. Bar = 10µm.  (b) Antigen 
competition.  Plk4 antibodies were pre-incubated with antigen or BSA as control and used for 
immunofluorescence staining of U2OS cells.  Bar = 10µm. (c) Co-localization of Plk4 with centrioles 
in G1 and G2 cells. Plk4 was stained by antibody and centrioles were visualized by EGFP-hCentrin.  
Bar = 1µm. 
 
Plk4 is present in the cell throughout mitosis 
The protein levels of Plk1 are subject to large changes over the course of the cell 
cycle (Golsteyn et al., 1995).  Plk4 may be cell cycle regulated because levels of Plk4 
mRNA have been reported to increase in cells released from a G0 arrest (Fode et al., 
1996), but no data on the protein levels of this kinase have been presented.  However, 
the above immunofluorescence study on endogenous Plk4 in U2OS cells suggested 
that Plk4 is located at the centrosome throughout the cell cycle, thus arguing against 
drastic alterations in the protein levels of this kinase.   
Unfortunately, the anti-Plk4 antibody did not detect the endogenous kinase by 
Western blot analysis, most likely due to the low abundance of Plk4.  Therefore, 
immunoprecipitations from total extracts prepared from synchronised cells were 
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attempted.  293T cells were synchronised with either a double-aphidicolin block or by 
a nocodozale induced mitotic arrest to achieve S- and M-phases, respectively.  G1 
cells were obtained by releasing cells from a nocodazole induced mitotic arrest for 
two hours.  As seen in Figure 19, Plk4 was immunoprecipitated at similar amounts 
from S-, M- or G1 phase cell extracts.  Consequently, the levels of Plk4 do not vary 
greatly over the course of the cell cycle, and this result is consistent with the previous 
immunofluorescence data.   
 
 
 
 
Figure 19. Plk4 is present in the cell throughout the cell cycle.  293T cells were synchronised in S-, 
M- or G1 phases as described in Methods.  Immunoprecipitations were performed from similar 
amounts of cell lysate by incubation with anti-Plk4 antibody (IP Plk4) or control IgG (mock IP).  
Immunocomplexes were analysed by immunoblotting using anti-Plk4 antibodies.  Protein amounts 
present in lysates used were verified by Bradford assay (not shown) or by probing with anti-tubulin 
antibodies.  The strong band running at 50 KDa is rabbit IgG.   
 
Overexpression of active Plk4 causes centrosome overduplication 
The transient expression of epitope-tagged Plk4 in U2OS and HeLa cells confirmed 
the centrosomal localization of this kinase but did not reveal obvious associations 
with cleavage furrows or intranuclear structures, in line with the observations of the 
endogenous protein mentioned above.  Most interestingly, overexpression of wild-
type Plk4 in U2OS or HeLa cells for 48 hours resulted in a striking multiplication of 
Plk4-positive dots (Figure 20a), whereas most cells overexpressing catalytically 
inactive (D154A) kinase did not. These structures also formed asters in a microtubule 
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regrowth assay (Figure 20b).  When overexpressed in cells, several centrosomal 
proteins are known to form aggregates seen as multiple punctate structures in the cell 
cytoplasm (Casenghi et al., 2003; Andersen et al., 2003), and these are most likely due 
to the presence of coiled-coil structures in the ovexpressed protein.  However, the 
Plk4 induced structures stained positive not only for the overexpressed kinase but also 
for several known centrosomal and centriolar components (Figure 20c).  In particular, 
the centriolar markers centrin-2, C-Nap1, γ-tubulin and polyglutamylated tubulin were 
located to these dots, as well as the known centrosomal proteins FOP, Cap350 and 
pericentrin (Figure 20c).    The positive result obtained with the GT335 antibody 
directed against stabilised tubulin revealed that these dots contain organised 
microtubular structures.  The staining of these punctuate structures with centrosomal 
markers therefore suggested that they constitute either centrioles or centriole 
precursors. 
 
 
 
 
Figure 20. Overexpression of Plk4 leads to the overproduction of centrioles.  (a) U2OS cells were 
transfected with myc-tagged wild-type (wt) or catalytically inactive (D154A) Plk4 for 48h.  The 
overexpressed kinase was detected with anti-myc 9E10 antibody (green) and centrioles were stained 
with anti-C-Nap1 antibody (red). Bar = 10µm.  (b) U2OS cells overexpressing myc-tagged wt Plk4 
were incubated on ice for 30 min to depolymerise microtubules.  Cells were then incubated in warm 
medium for 30 seconds to induce microtubule polymerisation, followed by immediate fixation and 
staining with antibodies against α-tubulin (green) and myc (red).  Note formation of multiple asters (c) 
wt Plk4 overexpressing cells were probed with anti-myc antibodies (green) or antibodies against 
centrosomal proteins (red).  Bars = 10µm 
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Confirming this conclusion, an electron microscopic analysis of cells from the 
aforementioned cell line induced to express wild-type Plk4 revealed multiple 
structures resembling canonical centriole cylinders (Figure 21). In contrast, the 
majority of cells expressing catalytically inactive Plk4 showed only two centrioles 
(Figure 21). Taken together, these data demonstrate that excess Plk4 activity results in 
centriole amplification. 
 
 
 
 
Figure 21. The structures formed by excess Plk4 are centrioles.  Electron micrographs showing the 
presence of multiple centrioles in cell line induced for 48h to express wt Plk4 (left panels), whereas 
most cells expressing the D154A mutant show only two centrioles (right panel). Cells were fixed in 
glutaraldehyde and stained with uranyl-acetate and lead citrate.  Bar = 500 nm.  Electron microscopy 
kindly performed by Y-D Stierhof, ZMBP, University of Tübingen.   
 
 
 A priori, centriole amplification can arise through bonafide centriole 
overduplication during S phase or through cell division failure (Meraldi et al., 2002a; 
Nigg, 2002; Sluder, 2004). To distinguish between these possibilities, U2OS cells 
were transfected with Plk4 and then treated with or without aphidicolin. This inhibitor 
of replicative DNA polymerases causes cells to arrest in S phase and prevents passage 
through mitosis. Moreover, in aphidicolin-treated U2OS cells centrosomes are known 
to overduplicate (Balczon et al., 1995; Meraldi et al., 1999a). When compared to 
controls, wild-type Plk4 induced extensive centrosome amplification above 
background regardless of the presence or absence of aphidicolin (Figure 22a and b), 
indicating that it caused bonafide centrosome overduplication. Supporting this 
conclusion, active Plk4 also triggered centrosome amplification in aphidicolin-treated 
HeLa cells (Figure 22c), in which centrosomes do not spontaneously overduplicate 
during S phase arrest (Meraldi et al., 2002a). In contrast, catalytically inactive D154A 
Plk4 caused some centrosome amplification above background in untreated U2OS 
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cells (Figure 22a), but this was reduced to a level typical of aphidicolin-treated cells 
when cell division was suppressed (Figure 22b). These results indicate that only an 
excess levels of wild type kinase increased centrosome numbers whereas the 
catalytically inactive mutant kinase caused centrosome amplification through 
occasional division failure, presumably via a dominant-negative mode of action. 
 
 
 
 
 
 
Figure 22.  Excess wt Plk4 leads to centriole overduplication in arrested cells.  Histograms show 
the percentages of cells with excess (>4) centrioles in U2OS (a,b) or HeLa (c) after incubation for 48 h 
with (b,c) or without (a) aphidicolin. Cells were either untransfected (-) or transfected with wt or 
D154A Plk4, as indicated. Data from three independent experiments, counting 150 cells each; error 
bars indicate standard deviation. 
 
 
   The evidence so far suggested that Plk4 activity was responsible for the 
overproliferation of centrosomes, however no evidence for a direct role of Plk4 at the 
centrosome had been obtained.  We therefore set out to find Plk4 mutants that did not 
localise to centrosome, yet remained catalytically active.   
A previous report had revealed the importance of the C-terminal sequences in 
localising Plk4 to the centrosome (Leung et al., 2002).  In those studies, when  a short 
section of the C-terminus including the polo-box had been deleted, the overexpressed 
truncation mutant no longer was recruited to the centrosome. Therefore, we generated 
several epitope-tagged Plk4 deletion constructs (Figure 23a) and examined their 
subcellular localization after overexpression in U2OS cells (Figure 23b).  In 
particular, a close examination of the polo-box domain alignment in Figure 8 
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prompted us to delete the polo-box as defined by the previously published structure of 
the polo-box (Leung et al., 2002), thus generating the Plk4(1-888) mutant.   
Abolishing the Plk4 polo-box did not alter the localisation of this kinase (Figure 23b) 
whereas a myc-fusion fragment consisting of only the polo-box sequences (Plk4 888-
970) was not recruited to the centrosome.  These data suggest that the polo-box was 
not sufficient to confer localisation.  Furthermore, they contrast with the role of the 
Plk1 polo-box in the recruitment of that kinase to intracellular structures (Lee et al., 
1998).  However, a mutant with a more extensive deletion of the C-terminus including 
most of the putative secondary structures found by predictive programs (Plk4 1-638, 
see Figure 9) was not found at the centrosome but in the cytoplasm instead (Figure 
23b).  The deleted fragment itself, however, was capable of localising to the 
centrosome (Plk4 638-970,).  This result reveals that the sequences upstream of the 
polo-box are required for centrosome localisation. 
Taken together, the recruitment of overexpressed fragments of Plk4 to the 
centrosome required sequences located in the C-terminal, non-catalytic domain, 
supporting the conclusion that both the C-terminal polo-box motif and additional 
upstream motifs (the so-called cryptic polo-box) contribute to confer correct 
localization (Leung et al., 2002).   
Next, these various deletion mutants of Plk4 were assayed for their ability to 
induce centrosome overduplication in arrested cells (Figure 23a, c).  As before, myc-
tagged deletion mutants of Plk4 were transfected into U2OS cells in the presence of 
aphidicolin for 48 hours.  As expected, none of the mutants lacking the catalytic 
domain were able to increase centriole numbers. The Plk4 mutant (1-888) lacking the 
polo-box motif, but still able to localise to centrosomes (Figure 23b), induced 
centriole overduplication, whereas the Plk4 (638-970) mutant lacked this ability 
(Figure 23c).  A summary of these results is given in Figure 23a.  Taken together, 
Plk4 deletion constructs able to localise to the centrosome and which contain a kinase 
domain are capable of inducing centriole overduplication. 
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Figure 23.  Centriole overduplication depends on centrosome localization of Plk4.  (a) Schematic 
summarizing myc-tagged Plk4 deletion mutants that were assayed for localisation and ability to induce 
centrosome overduplication.  (b) U2OS cells were transfected, incubated in medium containing 
aphidicolin for 48 h and processed for immunofluorescence microscopy, using anti-myc (9E10) 
antibody to visualize ectopic Plk4 (green) and anti-C-Nap1 antibody (red) to monitor centriole 
numbers.  (c)  Histogram shows percentage of cells with excess (>4) centrioles.  Data are from three 
independent experiments, counting 120-150 cells each, with error bars indicating standard deviations.   
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Finally, we wanted to confirm the catalytic activity of these Plk4 deletion 
mutants.  Using the approach shown in Figure 13, the various myc-tagged Plk4 
deletion mutants were transfected into 293T cells for 24 hours and purified by 
immunoprecipitation.  The purified proteins were then subjected to an in vitro kinase 
assay to investigate autophosphorylation.  As seen in Figure 24, both the Plk4 (1-888) 
and the Plk4 (1-638) showed catalytic activity.  The differences between these two 
mutants in the ability to induce centrosome overduplication therefore depended solely 
on the localisation of the overexpressed constructs in cells.   
 
 
 
 
 
Figure 24. The C-terminal deletion mutants of Plk4 are catalytically active.  N-terminal myc-
tagged Plk4 constructs were immunoprecipitated with myc antibodies from total cell lysate prepared 
from overexpressing 293T cells, subjected to an in vitro phosphorylation assay, transferred to a 
nitrocellulose membrane and exposed to film.  Left panel shows membrane probed with anti-myc 
antibody confirming immunoprecipitated deletion mutants, right panel shows autoradiogram revealing 
autophosphorylation.   
 
Plk4 homodimerises 
Previous work has revealed the dimerisation abilities of mouse Plk4 (Leung et al., 
2002), this feature being dependent on C-terminal domains.  Using directed yeast 2-
hybrid analysis, full length Plk4 was found to interact with itself (Figure 25).  In 
contrast, yeast cells transformed with full length Plk4 and empty bait or prey vectors 
did not grow on selective medium, showing that Plk4 was not autoactivatory.  These 
results therefore confirm previous observations on the dimerisation of mouse Plk4. 
 
 
 61
 
 
 
 
 
Figure 25. Plk4 interacts with itself in yeast 2-hybrid analysis.  Yeast cells were cotransformed with 
plasmids encoding Plk4 fused to the GAL4 DNA binding domain (Plk4-BD) and the Plk4-activation 
domain fusion (Plk4-AD).  After transformation, yeast cells were plated in three serial dilutions on 
non-selective (-WL) or selective medium (-WAL) for 5 days.  Yeast cotransformed with bait Plk4-BD 
and empty activation domain vector (AD), or Plk4-AD and binding domain vector (BD) were used as 
controls.  Note growth on selective medium of Plk4-AD/Plk4-BD transformed yeast only.   
 
 
Domain mapping was used to determine which region was required for the 
dimerisation of Plk4.  For this aim, myc-tagged Plk4 deletion mutants (see Figure 23) 
were assayed for their ability to bind Flag-tagged full length Plk4 in a co-
immunoprecipitation assay.  As shown in Figure 26, the Plk4(1-638) lacking C-
terminal regions was incapable of interacting with the full length kinase.  Conversely, 
the C-terminus of Plk4 (residues 638-970) was able to interact with wt Plk4, 
suggesting that this fragment functions as a dimerisation domain.   When the polo-box 
domain was removed, the resulting mutant Plk4(1-888) still interacted with wt Plk4.  
This suggests that the polo-box is not sufficient for Plk4 dimerisation.   
In summary, the data presented here confirms previous reports on the 
dimerisation of Plk4.  Furthermore, this ability is dependent on C-terminal domains 
even though the polo-box domain alone is not essential.  The role of dimerisation in 
the function of Plk4 is unclear and, moreover, the possibility of oligomerisation 
instead of dimerisation remains to be investigated.   
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Figure 26. The C-terminus of Plk4 is required for dimerisation.  Cos7 cells were co-transfected 
with Flag-tagged full length Plk4 and myc-tagged Plk4 constructs or myc vector alone as control.  
Success of overexpression was monitored by immunoblotting total lysate with myc-antibodies (top 
panel).  Full length Flag-Plk4 was immunoprecipitated from total cell extracts using Flag-antibodies, 
eluted with Flag-peptide, and immunocomplexes were analysed for the presence of myc-tagged 
deletion constructs by probing with anti-myc antibodies (middle panel).  Immunoprecipitation of  Flag-
Plk4 was confirmed by Western blot analysis using anti-Flag antibody (lower panel).   
 
 
Overexpression of Plk4 leads to the formation of centriole precursors 
Striking evidence for the direct action of Plk4 at the centrosome was found when 
centrosomes from cells induced to express wild type kinase for 16 hours were 
analysed by electron microscopy.  Specifically, electron microscopy revealed  
conspicuous morphological changes in the form of multiple patches of electron dense 
material on the surface of centrioles, which often formed rosette-like structures in 
transverse cross-sections (Figure 27, top panels).  Longitudinal cross-sections 
revealed that these unusual structures generally formed at the proximal ends of 
centrioles (Figure 27, lower panels).  An intriguing interpretation of this data is that 
they could represent centriole precursor material recruited to centriole assembly sites 
at the proximal ends of centrioles.   
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Figure 27. Overexpression of wt Plk4 induces morphological alterations of the centrosome.  
Centrosome alterations induced by excess Plk4 activity. Expression of Plk4-FLAG was induced in 
U2OS cells for 16 h before fixation in glutaraldehyde and analysis by electron microscopy.  Electron 
micrographs of transverse (upper panels) and longitudinal sections (lower panels) of centrioles are 
shown emphasizing electron dense material at proximal ends.  Bar = 500 nm. Electron microscopy 
kindly performed by Y-D Stierhof, ZMBP, University of Tübingen. 
 
 
In support of this view, rosette-like structures induced by wild-type Plk4 could 
also be visualized by high-resolution immunofluorescence microscopy with 
antibodies against centrin (Figure 28, top row of panels), a centriolar marker 
implicated in centriole duplication (Salisbury et al., 2002). Plk4 did not exactly co-
localize with rosettes (Figure 28), but was always located on the inside of these 
structures, possibly on the surface of centrioles.  
To extend these findings and uncover additional proteins that localize to these 
rosettes, antibodies against other centrosomal proteins were used.  Most notably, 
centrin positive rosettes were also stained with overexpressed GFP-CPAP or with 
antibodies directed against CPAP (Figure 28), the putative human homologue of  Sas-
4 required for centriole duplication in  C. elegans (Leidel and Gonczy, 2003).  In 
contrast, antibodies against C-Nap1, γ-tubulin or polyglutamylated tubulin did not 
stain rosettes (Figure 28), implying that these centriolar proteins are recruited after 
centrin and CPAP.  These results therefore reveal a sequential recruitment of 
centriolar proteins to Plk4 induced precursor structures.  An attractive conclusion 
from these data is that centrin and CPAP may form part of a putative complex 
required for the earliest stages of centriole assembly. 
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Figure 28. Plk4 induces the formation of centriole precursors.    Expression of Plk4-FLAG was 
induced in U2OS cells for 16 h before cells were stained with antibodies to detect centrin (green) and 
Flag-Plk4 or several centrosomal proteins (red) in preparation for immunofluorescence microscopy.  
Bars = 0.5µm   
 
 
To confirm whether the electron dense structures observed in Figure 28 were 
indeed centrin and CPAP positive rosettes observed by immunofluorescence, cells 
induced to overexpress wt Plk4 for 16h were used for pre-embedding immuno-gold 
electron microscopy.  When cells were labelled with antibodies directed against the 
Flag epitope tag of over-expressed wt Plk4, gold particles were seen to decorate the 
base of prominent bud-like structures close to the parental centriole surface in both 
transverse and longitudinal cross-sections (Figure 29a).  CPAP antibodies recognised 
similar bud-like structures, (Figure 29b) although transverse cross-sections of 
centrioles revealed that CPAP localized more peripherally, in close proximity to Flag 
antibodies (compare schematic diagrams in the top right-hand  panels in Figure 29a 
and b).  Furthermore, longitudinal views of centrioles revealed that electron dense 
structures at the proximal ends of centrioles were positive for both Flag and CPAP 
antibodies (compare lower left panels of Figure 29a, b and Figure 27).  It is therefore 
likely that rosettes seen by electron and immunofluorescence microscopy are similar 
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and, moreover, the use of electron microscopy may permit the observation of earlier 
structures due to greater magnification.   
 
 
 
 
 
Figure 29. Plk4 and CPAP localise to centriole precursor material.  Pre-embedding immuno-EM 
localisation of  (a) Flag-Plk4 and (b) CPAP to centrosomes in Plk4 expressing cells.  Panels show 
electron micrographs and schematic diagrams depicting nano-gold particles on centriole precursors for 
clarity, of transverse (upper panels) and longitudinal centrioles (lower panels).  Electron microscopy 
kindly performed by Y-D Stierhof, ZMBP, University of Tübingen. 
 
 
Taken together, the increased levels of wt Plk4 at the centrosome leads to 
distinct structural changes involving the recruitment of material containing centrin 
and CPAP.  One tantalizing interpretation of these data is that the centriolar rosettes 
induced by Plk4 activity represent multiple initiation sites for centriole assembly.  
Further analysis of these putative precursor structures may thus lead to a better 
mechanistic understanding of centriole duplication.  Another surprising finding is that 
the formation of nascent centrioles is not restricted to a single assembly point on the 
parent centriole.  In these overexpression studies, excess Plk4 may therefore mark 
additional sites for the recruitment of centriolar material and permit the parallel 
assembly of multiple pro-centrioles on the circumference of the parent centriole. 
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Plk4 phosphorylates CPAP and its own C-terminus in vitro 
Given the evidence so far in support of a direct activity of Plk4 at the centrosome, we 
asked whether this kinase could phosphorylate centrosomal proteins in vitro.  Obvious 
substrate candidates for use in a kinase assay included proteins involved in centriole 
duplication, such as CPAP.  To screen for in vitro substrates, the GST-tagged kinase 
domains of wt and catalytically inactive Plk4 consisting of residues 1-265 was used.   
Since autophosphorylation of full length wt Plk4 had been observed in previous 
experiments (see Figure 13), the possibility of the C-terminus of Plk4 acting as an 
internal substrate was explored.  A bacterially expressed and purified GST-tagged 
fusion of a previously used C-terminal fragment of Plk4 containing residues 638 to 
970 (see Figure 13) was used as a possible substrate.  The kinase domain of Plk4 
phosphorylated this recombinant C-terminal domain (Figure 30) revealing additional 
phosphorylation sites besides those within the kinase domain.  Whereas 
autophosphorylation of the Plk4 kinase domain most likely involves the conserved 
threonine residue 170 required for full catalytic activity,  the role of phosphorylation 
sites in the C-terminus remains unclear and requires further analysis.  
 
 
 
 
 
Figure 30. The C-terminus of Plk4 is a substrate.  The bacterially expressed and purified GST-
tagged C-terminus of Plk4 (residues 638-970) was used as substrate in an in vitro kinase assay together 
with recombinant Plk4 kinase domain as enzyme in the presence of [γ-32P]-ATP .  (a) The kinase assay 
was separated by SDS-PAGE and stained with Coomassie Blue.  (b) Autoradiogram of kinase assay 
showing phosphorylation of the C-terminus.   
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Using a similar approach, full length and fragments of CPAP were purified from 
transfected COS7 cells by immunoprecipitation, and subjected to a kinase assay.  The 
plasmid for full length GFP tagged CPAP was a kind gift of P. Gönczy (Swiss 
Institute for Experimental Cancer Research, Lausanne, Switzerland).  Plk4 clearly 
phosphorylated N-terminal fragments of CPAP and the full length protein, although 
the latter only weakly (Figure 31).  Unfortunately, no results for the C-terminus of 
CPAP could be obtained as this was not available. 
 
 
 
 
 
 
Figure 31. CPAP is an in vitro substrate of Plk4.   GFP tagged full length and fragments of CPAP 
were expressed in Cos7 cells and immunoprecipitated from total cell extracts using anti-GFP 
antibodies.  Immunocomplexes were subjected to an in vitro kinase assay with Plk4(1-265) in the 
presence of  [γ-32P]-ATP.  (a) The kinase assays were separated by SDS-PAGE and immunoblotted 
with anti-GFP antibodies to quantify substrate.  (b)  Autoradiogram of the same immunoblot, showing 
phosphorylation of CPAP-GFP fragments marked by asterisks (*).   
 
 
Since CPAP localised close to overexpressed Plk4 on putative centriole 
precursors observed by electron microscopy in Figure 29, this human homologue of 
Sas-4 could be a potential in vivo substrate and would thus be an attractive candidate 
protein for further study.  Further characterization of in vitro phosphorylated CPAP 
would also provide data on currently unknown consensus motifs of Plk4 target sites.  
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Continued screening of centrosomal proteins is therefore a promising approach to 
identify additional substrates of Plk4.  
 
Centrosome duplication is blocked by Plk4 inhibition  
To corroborate a critical role for endogenous Plk4 in the regulation of centrosome 
duplication, loss-of-function experiments were performed. These experiments took 
advantage of the fact that certain mammalian cells such as U2OS reduplicate their 
centrosomes under a prolonged S-phase block.  Inhibition or inactivation of proteins 
necessary for centrosome reproduction therefore prevent reduplication in such cells, 
as described in previous studies (Stucke et al., 2002; Meraldi et al., 1999a; Matsumoto 
et al., 1999b; Chen et al., 2002a).   
As a first approach, purified anti-Plk4 antibodies, or non-immune 
immunoglobulins for control, were microinjected into the cytoplasm of 
asynchronously growing U2OS cells. Following treatment with aphidicolin for 64 
hours to induce centrosome overduplication, cells were co-stained with secondary 
anti-rabbit antibodies to visualise injected cells, and with anti-γ-tubulin antibodies to 
monitor centrosome numbers (Figure 32a,b).  Whereas approximately 50% of cells 
injected with control antibodies contained multiple centrosomes, most cells injected 
with anti-Plk4 antibodies displayed normal centrosome numbers, indicating that 
antibody-mediated inhibition of endogenous Plk4 prevented centrosome 
overduplication.   
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Figure 32. Microinjection of Plk4 antibody inhibits centrosome overduplication.  (a) U2OS cells 
were microinjected with purified anti-Plk4 antibodies or control rabbit IgG, followed by incubation in 
medium containing aphidicolin for 64 h.  After fixation, secondary anti-rabbit IgG antibodies were used 
to visualize injected cells (green) and centrosomes were detected with anti-γ-tubulin antibody (red). 
Insets emphasize inhibition of centrosome overduplication in anti-Plk4 antibody-injected cells as 
compared to controls. (b) Histogram shows the percentage of microinjected cells with increased 
numbers (>2) of centrosomes.  Data are from three experiments, counting 150-200 injected cells each 
time, with error bars showing standard deviations.   
 
As a second, complementary approach to abrogate Plk4 function, centrosome 
overduplication assays were performed in U2OS cells from which endogenous Plk4 
had been depleted by siRNA (Figure 33).  Cells were transfected with a Plk4-specific 
duplex RNA oligonucleotide for 24 hours, before aphidicolin was added for 64 hours. 
Staining with anti-γ-tubulin antibodies was then used to evaluate centrosome numbers 
in those cells that had been successfully depleted of endogenous Plk4, as judged by 
the complete absence of a centrosomal Plk4 immunofluorescence signal (Figure 33a). 
As compared to cells treated with a control siRNA duplex (GL2; (Elbashir et al., 
2001), siRNA mediated depletion of Plk4 strongly suppressed the centrosome 
reduplication phenotype (Figure 33b) in these cells. Thus, antibody-microinjection 
and siRNA-mediated protein depletion concur to demonstrate that suppression of Plk4 
function interferes with centrosome overduplication in U2OS cells.  
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Figure 33.  Depletion of Plk4 by siRNA blocks centrosome overduplication.  (a) U2OS cells were 
transfected with either control (GL2) or Plk4 siRNA duplexes.  24 h after transfection, aphidicolin was 
added for an additional 64 h before cells were fixed and stained for Plk4 (green) and γ-tubulin (red).  
Bar = 10 µm.  Insets highlight inhibition of centrosome overduplication in Plk4 depleted cells (b) 
Histogram shows the percentage of siRNA transfected or untransfected (-) cells with increased 
numbers (>2) of centrosomes. Results are from three independent experiments, counting 200 cells each, 
and error bars denote standard deviations. 
 
Depletion of Plk4 causes progressive loss of centriole numbers  
All results obtained so far indicated that Plk4 plays a critical role in triggering 
centriole duplication during S phase.  However, we wanted to analyse asynchronously 
dividing cells and found that HeLa cells were better suited for these studies.  More 
precisely, transfecting HeLa cells with siRNA duplexes targeting Plk4 for 48 hours 
resulted in a more efficient depletion of endogenous protein when observed by 
immunofluorescence microscopy (Figure 34).  Furthermore, significant numbers of 
cells were observed to contain only one centriole when stained with anti-γ-tubulin 
antibodies.  Since dividing cells were expected to give the most striking phenotype 
upon siRNA mediated Plk4 depletion, we focused our analysis on mitotic cells.   
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Figure 34. Depletion of Plk4 by siRNA leads to a reduction in centriole numbers in interphase 
cells.  HeLa cells were transfected with Plk4 siRNA or GL2 duplex as control for 48 hours.  Cells were 
fixed and prepared for immunofluorescence microscopy by staining with anti-Plk4 antibodies (green) 
and anti-γ-tubulin antibodies (red).  Arrows point to centrioles.  Bar = 10µm.  Note efficient depletion 
of Plk4 signal and the presence of only one centrosome in Plk4 depleted cells. 
 
 
In our approach to investigate mitotic figures, HeLa cells were transfected with 
siRNA duplexes targeting Plk4 and fixed after 24 to 48 hours.  To simultaneously 
analyze both spindle structures and centriole numbers at spindle poles, fixed cells 
were co-stained with antibodies against α-tubulin and centrin-2, respectively. After 
depletion of Plk4 for 24 hours, the vast majority of all mitotic cells still appeared to 
form bipolar spindles, but after 48 hours, many monopolar spindles were observed 
(Figure 35b). Counting of centriole numbers revealed that virtually all cells treated 
with control siRNA-duplexes showed the expected four centrioles, two at each pole, 
regardless of the time of treatment (Figure 35a).  In contrast, examination of the Plk4-
depleted cells revealed progressive aberrations in spindle morphology and a stepwise 
reduction in centriole numbers (Figure 35a,b). At 24 hours after Plk4 depletion, most 
mitotic cells displayed bipolar spindles, but many had only single centrioles at each 
pole (Figure 35b, panel B). In addition, some monopolar spindles with 2 centrioles at 
the centre could be seen (Figure 35b, panel C).   
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Figure 35. Depletion of Plk4 causes progressive reduction in centriole numbers.  HeLa cells were 
transfected with control (GL2) or Plk4 siRNA duplexes for 24 or 48 h.  After fixation, cells were 
stained with rabbit anti-centrin-2 (green), mouse anti-α-tubulin (red) antibodies and DAPI (blue). (a) 
Histogram shows the percentages of mitotic cells containing 1, 2 or 4 centrioles at 24 and 48 hours, 
counting 52 mitotic cells for each time point.  (b)  Left panels summarize the phenotypes of mitotic 
cells transfected with Plk4 siRNA duplexes, alongside with models depicting centriole numbers and 
spindle morphology for clarity. Left panels show centrioles (centrin) whereas colour panels show 
centrioles (centrin; green), α-tubulin (red) and DNA (DAPI, blue). Bar = 10µm. The numbers on the 
right indicate the frequency (in %; n=52) of each phenotype after 24 h and 48 h. 
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After 48 hours, bipolar spindles still formed occasionally, but most of these 
showed only a single centriole at one pole (Figure 35b, panel D). In these cells, the 
acentriolar pole was lacking astral microtubules (Figure 35, panel D), consistent with 
the notion that centrioles are required for astral microtubule formation (Khodjakov et 
al., 2000; Megraw et al., 2001).  Most strikingly, the predominant 48 hour phenotype 
was constituted by monopolar spindles with a single centriole at the centre (Figure 
35b, panel E).  In control experiments, monopolar spindles produced by depletion of 
the class 5 kinesin motor Eg5 (Blangy et al., 1995; Harborth et al., 2001) were 
analyzed in parallel. Eg5 is required for centrosome separation at the onset of mitosis 
but its depletion would not be expected to affect centriole numbers. Indeed, four 
centrioles could readily be detected in the vast majority of monopolar spindles 
produced upon Eg5 depletion (Figure 35b, phenotype F).  Taken together, the above 
results demonstrate that cells depleted of Plk4 progressively loose centrioles with 
continued passage through the cell cycle, indicating that Plk4 is indispensable for 
centriole duplication. 
The above results suggested that the centrosome is not strictly required for the 
formation of a bipolar spindle, consistent with previously published data (Khodjakov 
et al., 2000).  In support of this notion the proteins Aurora A and NuMa, two proteins 
required for the correct formation of bipolar spindles (reviewed in (Meraldi et al., 
2004; Compton and Cleveland, 1994) were investigated in cells depleted of Plk4 
(Figure 36).  Cells were prepared for immunofluorescence microscopy by staining 
with anti-centrin antibody to visualise centrioles and antibodies directed against 
Aurora A or NuMa.  As seen in Figure 36, both proteins still localised properly to 
both poles in cells exhibiting bipolar spindles with an acentriolar pole.  This result 
suggested that the localisation of Aurora A and NuMa is not dependent on the 
presence of centrioles and therefore both proteins should be able to complete their role 
in spindle formation.  In conclusion, the above data is consistent with reports showing 
that centrioles are not essential for spindle formation (Khodjakov et al., 2000), and 
suggest that these cells should be able to complete mitosis. 
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Figure 36.  Normal localisation of NuMa and Aurora A to the acentriolar pole of spindles.  HeLa 
cells transfected with control GL2 or Plk4 siRNA for 48 hours were prepared for immunofluorescence 
microscopy by labelling with antibodies against (a) Aurora A or (b) NuMa.  Centrioles were visualised 
by staining with anti-centrin antibodies, spindles with anti-α tubulin.  Bar = 10µm. 
 
 
 
We wanted to confirm that cells depleted of Plk4 do not suffer a cell cycle 
arrest.  HeLa cells transfected with Plk4 siRNA duplex for 48 hours were harvested 
and prepared for flow cytometric analysis, and depletion of kinase was confirmed by 
immunofluorescence microscopy (not shown).  Cells transfected with GL2 duplex for 
the same length of time were used as control.  As seen in Figure 37, the mitotic profile 
of Plk4 depleted cells appears normal, with G1-, S- and M-phase cells in similar 
proportions to the control transfected cells.  A lack of this kinase therefore does not 
affect the normal mitotic progression of cells, at least not during the first 48 hours of 
depletion.   
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Figure 37. siRNA silencing of Plk4 does not arrest the cell cycle.  HeLa cells were transfected with 
Plk4 or control GL2 siRNA duplex for 48 hours.  After fixation, cells were stained with propidium 
idiodide and prepared for FACS analysis.  Histograms show the mitotic profile of a representative 2000 
cells from a total of 10000 cells transfected with control or Plk4 duplex.   
 
The evidence so far suggested that cells depleted of Plk4 and exhibiting only 
one centriole but with bipolar spindles should be able to complete cytokinesis.  We 
therefore searched for acentriolar progeny cells that should have inherited the 
acentriolar pole of the mitotic spindle.  Since the centrosome is important for the 
organisation of the cytoskeleton, these cells were also predicted to have a disorganised 
microtubule network.  HeLa cells were transfected with Plk4 siRNA duplex for 72 
hours and stained with C-Nap1 antibodies to visualise the centrosome, and α-tubulin 
antibodies to stain the microtubule cytoskeleton.  As shown in Figure 38, several cells 
depleted of Plk4 for 72 hours lacked centrioles indicating that acentriolar progeny 
cells were generated.  The cytoskeleton also appeared diffuse and disorganised when 
compared to control siRNA duplex transfected cells but, surprisingly, this was 
irrespective of whether a cell still contained or centriole or not.  Depletion of Plk4 
therefore appears to affect the cytoskeletal organisation to some degree, and this may 
be unrelated to its centrosomal function.   
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Figure 38.  Depletion of Plk4 by siRNA leads to the formation of acentriolar cells.  Centrosomes 
were monitored by labelling with anti-C-Nap1 antibodies (red), the cytoskeleton by staining with anti-
α tubulin.  Bar = 10µm. 
 
In summary, depletion of Plk4 leads to the inhibition of centriole duplication.  
However, a lack of Plk4 was not consistent with a block in the cell cycle and therefore 
cells continue to divide until all centrioles are lost.  Presently, it is unclear if 
acentriolar cells continue to cycle and enter the subsequent cell cycles.   
 
Plk4 cooperates with Cdk2, CP110 and Hs-SAS6 to permit centriole duplication 
As highlighted in the introduction, several proteins such as γ- and ε-tubulin, centrin, 
CP110 and Hs-Sas6 have previously been shown to be required for centrosome 
duplication (Ruiz et al., 1999; Shang et al., 2002; Chang et al., 2003; Salisbury et al., 
2002; Chen et al., 2002b; Dammermann et al., 2004; Leidel et al., 2005; Sluder, 
2004).  Additionally, several protein kinases, including vertebrate Cyclin-dependent 
kinase 2 (Cdk2) (Meraldi et al., 1999b; Matsumoto et al., 1999a; Hinchcliffe et al., 
1999a), Plk2 (Warnke et al., 2004), calcium-calmodulin kinase II (Matsumoto and 
Maller, 2002), S. cerevisiae Mps1 (Fisk and Winey, 2001) and the C. elegans kinase 
Zyg-1 (O'Connell et al., 2001), have been implicated in the regulation of this 
fundamental cellular process. However, our understanding of centrosome duplication 
and its integration with the chromosomal cell cycle remains scarce.   
  To elucidate a possible relationship between Plk4 and Cdk2 in controlling 
centrosome duplication, cells harbouring the inducible Plk4 kinase were transfected 
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with either the Cdk2 inhibitor p27 or a catalytically inactive Cdk2 that had previously 
been shown to act as a dominant negative mutant (Figure 39a, b) (Meraldi et al., 
1999b).  After induction of Plk4 expression, the transfected cells were fixed, stained 
with anti-C-Nap1 antibodies and examined for overduplicated centrosomes.  
Compared to cells transfected by empty vector, both dominant negative Cdk2 and p27 
suppressed the Plk4 induced centrosome overduplication phenotype (Figure 39c).  To 
confirm and extend these results, cells were also arrested at the G1/S boundary with 
aphidicolin for 16h before Plk4 expression was induced for 24 hours in the presence 
or absence of roscovitin, a small molecule inhibitor of Cdk2 (Meijer et al., 1997). In 
the presence of aphidicolin alone, about 38 % of the U2OS cells displayed centrosome 
overduplication (Figure 39d), consistent with previous results (Meraldi et al., 1999a).  
Additional induction of Plk4 increased the proportion of cells showing centrosome 
amplification to 62 %, but no increase over background was seen in the presence of 
roscovitin (Figure 39d). Together, these results strongly indicate that overexpression 
of Plk4 cannot cause centrosome amplification in the absence of Cdk2 activity. In a 
final series of experiments, we also explored the relationship between Plk4 and two 
structural centrosomal proteins, CP110 and Hs-SAS6. When either one of these two 
coiled-coil proteins was depleted by siRNA, the percentage of cells showing multiple 
centrosomes in response to Plk4 induction was strongly reduced (Figure 39e). This 
indicates that both CP110 and Hs-SAS6 are required for Plk4-induced centrosome 
amplification.  
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Figure 39. Cooperation of Plk4 with proteins implicated in centrosome duplication.    A stable cell 
line carrying a tetracycline-inducible Plk4 cDNA was transiently transfected with epitope tagged 
dominant negative Cdk2 (Cdk2-DN) or p27 for 16h, after which Plk4 expression was induced for 24h.  
After fixation, centrioles were detected by staining with anti-C-Nap1 antibodies (red), whereas 
transfected cells expressing Cdk2-DN and p27 were identified using anti-HA and anti-myc antibodies, 
respectively (green). Cells were scored for overduplicated centrioles. Histograms summarize results 
from three independent experiments, counting 200 cells each, with  error bars denoting standard 
deviations.  (a,b) Immunofluorescence microscopy images showing cells transfected with Cdk2-DN (a) 
or p27 (b); bar denotes 10 µm and insets show enlargements of centrioles.  Note the reduction in 
centriole numbers in cells expressing Cdk-DN or p27, compared to untransfected cells.  (c) Histogram 
shows percentage of transiently transfected cells with overduplicated centrioles, using cells transfected 
with empty vector for control.  (d) Cells were treated with aphidicolin (aph) for 16h before induction of 
Plk4 in the presence or absence of Roscovitin (ros) for 24h.  Control cells were treated for 40h with 
aphidicolin only.  All cells were scored for overduplicated centrioles. (e) Cells were transfected for 24h 
with siRNA duplexes specific for CP110 or Hs-SAS6, or GL2 for control, before Plk4 expression was 
induced.  Histogram shows percentage of cells with overduplicated centrioles.  
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DISCUSSION 
 
Plk4 is the unusual member of the polo-like kinase family due to its non-canonical 
structure by having a long linker region and by its conspicuous lack of a second polo-
box motif (Swallow et al., 2005).  Reports have shown that Plk4 localises to the 
centrosome and other intracellular structures (Leung et al., 2002) and have provided 
evidence for a role in cell proliferation for this kinase (Fode et al., 1994; Fode et al., 
1996; Leung et al., 2002).  Most importantly, mouse knock-out studies have shown 
that Plk4 is required for development and for proper cell progression.  Specifically, 
mice deficient for Plk4 are embryonic lethal and Plk+/- heterozygotes show increased 
susceptibility to tumour formation in organs, showing that correct levels of Plk4 are 
essential for cell division (Ko et al., 2005).  Here, we have identified the Plk family 
member Plk4 as a critical regulator of centriole duplication in human cells.  Our 
conclusions are supported by both overexpression experiments and antibody-induced 
inactivation or siRNA-mediated depletion of Plk4 resulting in the formation of 
aberrant spindle morphologies.  We are therefore able to provide an explanation based 
on the function of Plk4 for the tumorigenic properties of the deregulated enzyme.   
Putative novel domains in Plk4 
The available literature on Plk4 does not contain much data on the undefined linker 
region.  A report has identified putative PEST domains which were revealed by a 
prediction program, and a further report suggested that deletion of these domains 
increases the half-life of the overexpressed kinase in mammalian cells (Fode et al., 
1994, Yamashita et al., 2001).  Furthermore, domain analysis has ascribed a 
dimerisation function to a region of this linker termed the cryptic polo box.  This C-
terminal region was also required for the centrosomal localisation of overexpressed 
Plk4 in mammalian cells (Leung et al., 2002).  Here, secondary structure prediction 
programs suggest that the extensive linker region can be tentatively divided into two 
parts.  Firstly, a genuine linker spans approximately half of the residues between the 
kinase and polo-box domains.  Secondly, a region corresponding to residues 600-800 
precedes the polo-box domain and consists of unidentified domains. Clearly, data 
generated by secondary structure prediction programs are only of limited value and 
may not reflect the actual structure of a protein in real life.  However, the domain 
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analysis presented here shows that this C-terminal region is necessary for dimerisation 
and for the recruitment of Plk4 to the centrosome.  This suggests that the C-terminus 
may be the domain interacting with other centrosomal proteins, and the evidence 
overall supports an in vivo function for the in silico predicted domains.  Since these 
structures are not identified by domain identification programs, they represent novel 
and previously uncharacterised motifs.  Indeed, since Plk4 lacks a second polo-box 
domain, these domains could function as a replacement, by acting as a targeting and 
interaction domain in conjunction with the single polo-box motif.  Further structural 
analyses of the C-terminal domain of Plk4 by NMR or crystallography would be an 
attractive path for the further characterisation of this kinase. 
 
Plk4 is required for centriole duplication 
In order to investigate the role of Plk4 and its requirement for centriole reproduction, 
Plk4 microinjection and siRNA mediated depletion experiments were carried out.  
Both approaches demonstrated that Plk4 is essential for centrosome over-duplication 
in the particular assay used.  In a further experiment, asynchronous cells were 
investigated.  Depletion of Plk4 resulted in the sequential loss of centrioles in 
successive cell divisions, resulting in fewer and fewer centrioles at the spindle poles 
and a progressive increase in abnormal spindle formation.  Occasional interphasic 
cells lacking centrioles were observed suggesting that cells with mitotic acentriolar 
bipolar spindles are able to complete cytokinesis.  This is consistent with the notion 
that centrioles are not necessary for the completion of cytokinesis or for spindle 
formation, but for the correct orientation of the bipolar spindle (Khodjakov et al., 
2000; Khodjakov and Rieder, 2004).  Moreover, a report has shown a requirement of 
the centrosome for proper cytokinesis and cell abscission (Piel et al., 2001).  In this 
report, mother centrioles were seen to travel to the cleavage furrow thus allowing 
putative signalling events to occur.  Cells depleted of Plk4 and lacking centrioles 
demonstrate that this function of the centriole is not strictly necessary for cytokinesis.  
Reports indicate, however, that acentriolar progeny cells generated by laser surgery or 
microdissection arrest in the following G1 phase (Maniotis and Schliwa, 1991; 
Hinchcliffe et al., 2001; Khodjakov and Rieder, 2001).  Whether these acentriolar 
cells produced by Plk4 depletion continue to cycle and form offspring remains to be 
determined.   
 81
 
De novo centriole formation in certain differentiated tissues is necessary for the 
formation of multiple basal bodies during ciliogenesis (Beisson and Wright, 2003).  In 
cell culture, de novo centriole formation can be observed after laser ablation of the 
centrosome (La Terra et al., 2005).   In this particular experiment, new centrioles are 
formed that cluster to create a microtubule organising centre, albeit disorganised and 
lacking the orthogonal relationship between two centrioles.    Since acentriolar cells 
were observed in the studies presented here, it is attractive to speculate that these cells 
are no longer able to reform a microtubule organising centre in the absence of Plk4.  
However, a direct role of Plk4 in de novo centriole formation is at present unknown. 
It is interesting to compare Plk4 with Zyg-1, a kinase clearly shown to play an 
essential role in centriole duplication in C. elegans (O'Connell et al., 2001).  Database 
searches do not reveal obvious homologues of Zyg-1 in vertebrate genomes and a 
more specific search for distant homologues in protein databases identified a putative 
chicken Plk4, amongst other kinases.  However, any significant similarity in peptide 
sequences was restricted to the catalytic domain since no other domains were found in 
Zyg-1.  Alignments of kinase domains used to assemble a phylogeny tree identify 
Polo-likes kinase and NimA related kinases as the closest homologues of Zyg-1.  
However, both kinase families were equally closely related to Zyg-1 such that no 
particular family member was classified as the closest human homologue of Zyg-1.  
Thus, although Plk4 and Zyg-1 do not show extensive sequence similarity, it remains 
possible that mammalian Plk4 may constitute the functional orthologue of the 
nematode kinase Zyg-1.  The search for interactors and possible mechanisms should 
therefore focus on human homologues of C. elegans proteins that are involved in 
centriole duplication and that show a dependency on Zyg-1.   
 
Overexpression of Plk4 induces the formation of ‘centriole precursors’ 
Several proteins putatively involved in centriole duplication have been shown to cause 
centrosome amplification when overexpressed in cells (Mussman et al., 2000; Xu et 
al., 1999; Leidel et al., 2005).  However, some proteins cause this phenotype upon 
overexpression by inducing a failure in cell division (Meraldi et al., 2002b; Sluder, 
2004).  In the work presented here, overexpression of active Plk4 in S-phase arrested 
cells resulted in genuine centriole overduplication in two different human cell lines, 
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suggesting that excess kinase activity is the cause for increased centriole over-
production.   
A seminal report has revealed the existence of a block to centriole reduplication 
that is intrinsic to the centriole itself (Wong and Stearns, 2003).  Excess amounts of 
Plk4 are sufficient to overcome this intrinsic block to centriole reduplication in 
cultured cells, a feature shared with only one other protein, human Sas-6 (Leidel et al., 
2004).  It would be attractive to speculate that  Plk4 and possibly Sas-6 are both 
involved in the mechanism that is responsible for preventing reduplication of 
centrioles.   
Most interestingly, overexpression of Plk4 lead to the formation of early 
structures that could be interpreted as centriole precursors.  These were seen as dark 
ring like structures by electron microscopy or as rosette-like staining patterns around 
the parental centriole in immunofluorescence studies.  As yet, the exact nature of 
these structures is undetermined.  However, two proteins that exhibited this particular 
staining pattern and localised to these structures were centrin and CPAP, whereas 
other centrosomal proteins did not.  Since both proteins or their homologues have 
been implicated in centriole duplication (Leidel and Gonczy, 2003; Salisbury et al., 
2002), a plausible involvement of both in the earliest stages of centriole assembly is 
an appealing interpretation.  Further screening of all known centrosomal proteins in 
terms of localisation to these putative precursor structures in conjunction with a 
careful synchronisation of the centrosome duplication cycle would be required for an 
analysis of these structures. 
Centrosomes are thought to duplicate according to the rule ‘once per cell cycle’ 
(Sluder, 2004; Delattre and Gonczy, 2004).  The surprising conclusion derived from 
these early rosette-like structures is the concept that, in the presence of excess Plk4, 
parental centrioles are able to nucleate and assemble multiple centrioles at the same 
time.  Given these results, an additional rule should therefore be added: ‘one new 
centriole per parent centriole’ (Figure 40) .  Centriole overduplication is therefore a 
consequence of either a prolonged S-phase and thus multiple rounds of sequential 
duplication events (Figure 40a), or of a single round of multiple centriole reproduction 
(Figure 40b).  It would be interesting to examine whether other proteins shown to 
induce centriole overduplication on overexpression proceed by this mechanism. 
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Figure 40. Two alternative modes of centriole overduplication in mammalian cells.  (a) Model 
showing a sequential mode of centriole duplication in S-phase arrested U2OS or CHO cells, thus 
violating the ‘only once per cell cycle’ rule of centrosome duplication.  (b) Alternatively, Plk4 
overexpressing cells produce multiple centrioles at once, contrary to the rule ‘only one daughter 
centriole per parent centriole’.  In normal cells, both rules must apply to maintain correct centriole 
numbers.   
 
Taking the above into consideration, the question arises as to the precise 
mechanistic function of Plk4.  Since overexpression of this kinase leads to the 
formation of multiple centriole assembly points on the parental centriole surface, a 
simple explanation would involve Plk4 marking additional assembly sites already 
present, a so-called ‘start gun’ for pro-centriole formation.  This would predict that the 
parental centriole has a limited and defined number of assembly sites located on the 
surface of its tubulin cylinder, and immediately poses the difficult question of how 
these sites are silenced during duplication in a normal wild type cell.   
An alternative function for Plk4 would be the activation and subsequent 
recruitment of proteins that themselves form centriole assembly sites, thus defining 
how many are produced.  If Plk4 is the functional homologue of Zyg-1, then the 
recruitment of proteins such as the human homologues of Sas-4 or Sas-6 to the 
centriole could be dependent on the activity of this kinase.   
This latter model would predict that the level of endogenous Plk4 in normal 
cells would be strictly limited, such that sufficient kinase activity could permit the 
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formation of only one centriole assembly site.  The limited Plk4 activity could 
initially be spread over the surface of the parent centriole, until a particular random 
location is more phosphorylated by chance than others.  This hyperphosphorylated 
site would then recruit proteins involved in the earliest stages of centriole formation 
and thus become the kinetically favoured spot where the procentriole is formed.  
Interestingly, the phosphatase PP2C-β was identified in a mass-spectrometric analysis 
of proteins co-immunoprecipitated with epitope tagged and overexpressed Plk4.  In a 
similar manner to the regulation of centrosome cohesion by Nek2 and the protein 
phosphatase 1 (Meraldi & Nigg, 2002), PP2C-β could act as an antagonistic 
phosphatase of Plk4.  Like centrosome cohesion, the regulation of centriole 
duplication would be dependent on the balance of phosphorylation and 
dephosphorylation activity of these proteins.  This would suggest that positive Plk4 
phosphorylation activity would outstrip the negative phosphatase activity during the 
initial step in centriole duplication, resulting in the hyperphosphorylation of a 
centriole assembly site.  Conversely, the effects of limited Plk4 activity would be 
dampened by the phosphatase during other stages of the cell cycle, thus preventing 
precocious centriole duplication.   
Alternatively, Plk4 could be asymmetrically located to one side of the paternal 
centriole, therefore fixing the assembly site purely in a spatial manner.  However, this 
would then beg the question of how such a polarised localisation would be achieved.  
In either case, a model requiring limited amounts of Plk4 would be consistent with the 
low level levels of this kinase seen by Western blot analysis of total cell extracts 
(Figure 17).   
Secondly, this model would also provide explanations for the self-interaction of 
Plk4, not reported for other Plk family members.  Similar to transcription factors or 
tubulin, dimerisation or oligomerisation would allow non-linear dose-dependent 
control over the formation of a complex involving Plk4.  However, the 
immunofluorescence data presented in Figure 18 point to a constant protein level 
throughout the cell cycle for this kinase.  Dimerisation may therefore be promoted by 
other mechanisms, such as phosphorylation by upstream kinases.  Alternatively, 
dimerisation of Plk4 could mirror the mechanisms governing transmembrane receptor 
tyrosine kinase transactivation leading to the formation of signalling complexes 
localised to membranes.  Dimerisation of this kinase could therefore collect sufficient 
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kinase activity at one point on the centriole surface to allow recruitment and activation 
of additional protein complexes and thus promote centriole formation.  At present, all 
these points are speculative and await further analysis of this fascinating kinase.   
 
Putative substrates of Plk4 
The cellular substrates of Plk4 remain to be identified, but the present data 
demonstrate that overduplication of centrosomes requires the presence of active Plk4 
at the centrosome. This suggests that the physiological substrates of this kinase will 
include centriolar and/or centrosomal proteins, and obvious candidates include the 
human homologues of Sas-4, -5 and -6.  Although the C. elegans Zyg-1 kinase is 
required for the recruitment of Sas-4 and Sas-6 to the centriole (Leidel et al., 2005), 
these proteins were not shown to be substrates of Zyg-1.  
Here, two in vitro  kinase substrates were found, namely CPAP, the human 
homologue of Sas-4, and the C-terminus of Plk4 itself.  The role of 
autophosphorylation of this kinase on the C-terminus is unclear.  However, it is 
notable that CPAP localises in close proximity to Plk4 on newly forming centriole 
precursor ‘buds’ seen by electron microscopy, and is therefore at the right place for a 
phosphorylation event.  CPAP could thus be an in vivo substrate of Plk4.  The results 
presented here are only a starting point and whether the phoshorylation of these 
substrates is actually of any physiological relevance requires further analysis.  
Identification of substrates would also allow the characterisation of a target 
consensus motif for this Polo-like kinase.  Interestingly, the activities of Plk1 and 4 on 
the exogenous substrate casein are different.  Plk1 and Plk4 were found to 
preferentially phosphorylate different subunits of casein, suggesting that these kinases 
act on different phosphorylation motifs.   Although Plk1 colocalises with Plk4 during 
late S-phase and G2 at the centrosome, it is possible that these kinases phosphorylate 
entirely different targets.   
In summary, it would be illuminating to reveal a complex regulating centriole 
duplication that is conserved from worms to mammals, containing evolutionarily 
related protein subunits.  Such a discovery would also explain the absence of Plk4 
homologues in higher plants which are deficient in centrioles.  Indeed, no obvious 
plant Plk4 homologues were encountered in sequence homology searches presented 
here.  Conversely, it would be interesting to speculate whether lower plants that are 
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able to form centriole-like structures (Gall, 2004) still have a functional homologue of 
Plk4.  However, databases contain very few sequences for Ginkgo or Bryophyte 
proteins, and the only available sequenced genomes are from higher plants such as 
Arabidopsis thaliana and rice.  Therefore, searches for plant Plk4 homologues will be 
difficult at present.   
 
 
Plk4 and Cdk2 co-operate to regulate centriole duplication 
Although information about the regulation of centriole duplication remains scarce, 
several studies point to an important role of Cdk2, acting in association with either 
cyclin E and/or A (Matsumoto et al., 1999b; Meraldi et al., 1999b; Hinchcliffe et al., 
1999b). Using an established centrosome overduplication assay (Balczon et al., 1995; 
Meraldi et al., 1999b; Matsumoto et al., 1999b), we found that Cdk2 was not able to 
cause centrosome overduplication in the absence of Plk4.  Conversely, overexpression 
of Plk4 did not result in centrosome amplification in the absence of Cdk2.  With 
regard to structural proteins implicated in centrosome duplication, the data presented 
here show that both CP110 (Chen et al., 2002a) and human Sas-6 (Leidel et al., 2005) 
are required for Plk4-induced centrosome amplification.  It is plausible that these 
coiled-coil proteins constitute important structural components required for centriole 
assembly. Taken together, these data indicate that Cdk2 and Plk4 cooperate in the 
regulation of centrosome duplication.  However, whether Cdk2 directly 
phosphorylates Plk4 remains unknown and further analysis will be necessary to reveal 
the regulatory kinases directly upstream of Plk4.   
 
Plk2 cannot substitute for Plk4 activity at the centrosome 
Recently, Plk2 has also been localized to centrosomes and implicated in centriole 
duplication (Warnke et al., 2004).  At present, it is not known whether Plk2 and Plk4 
cooperate.  However, it is to be emphasized that Plk2(-/-) mice are viable (Ma et al., 
2003), indicating that Plk2 function at the centrosome is not essential or that 
redundant mechanisms can substitute for Plk2.  Conversely, Plk4 is clearly required 
for murine embryonic development (Hudson et al., 2001) and, although Plk4 (-/-) 
embryos develop to stage E7.5, this is likely to reflect maternal contribution.  The 
embryonic lethality of the Plk4(-/-) animals  thus points to an indispensable function of 
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Plk4 in a key cellular process.  On the basis of the present data, we propose this key 
function to be the control of centrosome numbers.  
 
Plk4 is required for centriole duplication and flagella development in Drosophila 
During the course of the work discussed here, Bettencourt-Dias, Glover and co-
workers reported on the requirement of Plk4 for centriole duplication in flies 
(Bettencourt-Dias et al., 2005).  Drosophila only has the two Plk family members 
Plk1 and Plk4, and lacks homologues of Plk2 or 3 (Glover et al., 1998).  An siRNA 
screen of all Drosophila kinases by the same group had previously revealed 
centrosome aberrations in S2 cells depleted of Plk4 (Bettencourt-Dias et al., 2004) but 
not in cells lacking Plk1.  Further analysis of Plk4 depleted S2 cells demonstrated a 
loss of centrioles and the formation of broad, disorganised spindle poles in dividing 
cells, lending support to the notion that centrioles may be required for mitotic fidelity 
but not for proper spindle formation (Khodjakov et al., 2000; Khodjakov and Rieder, 
2001).   
In a parallel approach, Drosophila  mutant strains containing a hypomorphic 
allele consisting of a C-terminal deletion mutant of Plk4 were generated.  Larval 
neurones examined for centrosomal markers exhibited reduced numbers of 
centrosomes, but otherwise appeared normal.  Surviving adult mutant flies suffered 
from sterility and uncoordinated behaviour, and spermatocytes were found to lack 
flagella and basal bodies.  Mathematical modelling of the centrosome cycles in the 
cell divisions leading to the formation of mature spermatocyte in the spermatocyte 
cyst elegantly demonstrated a defect in centriole duplication.  In a final set of 
experiments, Glover and co-workers analysed the function of human Plk4 by siRNA 
depletion and showed its requirement for centriole duplication, thus providing an 
independent verification of the results presented here.  Taken together, Plk4 has a 
conserved function in controlling centriole duplication in two evolutionarily distant 
organisms.  It is therefore likely that the mechanisms involving Plk4 and its substrates 
in this fundamental process will be similar in both flies and humans. 
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Increased tumour formation in Plk4 +/- heterozygous mice may be caused by 
partially defective centrosome duplication. 
At first glance, it may seem surprising that overexpression of both active and 
catalytically inactive Plk4 caused centrosome amplification, albeit to a different 
extent. However, this observation can readily be explained by considering that active 
Plk4 brings about genuine centrosome overduplication, whereas the catalytically 
inactive mutant causes an increase in centrosome numbers by the likely induction of 
division failure, through a probable dominant-negative mechanism.  In line with 
earlier suggestions (Fode et al., 1996; Hudson et al., 2001; Swallow et al., 2005), this 
observation may hint at a second function of Plk4.  Although endogenous Plk4 was 
not detected at the cleavage furrow, it is possible that Plk4 directly regulates cell 
division (Leung et al., 2002; Hudson et al., 2001).  On the other hand, occasional 
division failure may also be a direct consequence of reduced centriole numbers caused 
by impaired centrosome duplication (Piel et al., 2001; Khodjakov and Rieder, 2001; 
Hinchcliffe et al., 2001; Gromley et al., 2003; Zou et al., 2005).  In these cases, the 
centrosome is thought to act as a signalling platform for proteins required for the final 
stages of cytokinesis and abscission.  Thus, the absence of the centrosome would be 
manifested in impaired signalling to the midbody and incomplete cytokinesis.   
Mice heterozygous for Plk4 were recently shown to display an increased 
incidence in tumour formation, due to Plk4 haploinsufficiency (Ko et al., 2005; 
Swallow et al., 2005).  Most interestingly, cells isolated from Plk4+/- animals showed 
multiple centrosomes, multipolar spindles and mitotic failures. This phenotype is 
remarkably similar to the one observed here upon overexpression of a dominant-
negative Plk4 mutant in human cells.  Conversely, reduced levels of Plk4 in mouse 
cells could also result in an aberrant spindle phenotype caused by impaired centriole 
duplication seen upon siRNA mediated Plk4 depletion. Therefore, the formation of 
aberrant spindles in Plk4+/- mouse cells upon mitogenic stimulation could be direct 
consequence of reduced numbers of centrosomes in dividing cells.  Although most of 
these cells are expected to enter apoptosis, some may survive and generate progeny 
cells with aberrant ploidy.  Since polyploid cells have been shown to promote 
tumorigenesis in mice (Fujiwara et al., 2005; Margolis, 2005), some Plk4 deficient 
cells are expected to become cancerous.  It will be important to analyse how Plk4 
haploinsufficiency causes the observed cellular defects and how these relate to the 
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increased incidence of tumours in animals. In particular, it will be interesting to test 
the hypothesis that a mechanism, centred on centrosome-related division failure and 
the generation of polyploid and aneuploid cells, may contribute to tumorigenesis in 
Plk4+/- animals.  
The present data have implications for the development of anti-cancer 
therapeutics based on the inhibition of Polo kinases. On the one hand, the increased 
tumorigenesis observed in Plk4+/- animals (Ko et al., 2005; Swallow et al., 2005) may 
raise concerns as to the safety of such drugs. In particular, one could argue that partial 
inhibition of Plk4 by anti-Plk drugs may be oncogenic and should be avoided. On the 
other hand, we have shown that Plk4 is indispensable for centrosome duplication in 
human cells and, therefore, cell proliferation is expected to halt in the face of strong 
inhibition of this kinase. From this latter perspective, Plk4 might actually constitute an 
attractive target for anti-proliferative therapeutic approaches.   
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METHODS 
 
Sequence analysis 
Plk4 peptide sequences were submitted to the PsiPred server for secondary structure 
predictions (McGuffin et al., 2001).  For identifying motifs and domains, sequences 
were analysed using ScanProsite (Gattiker et al., 2002) whereas coiled-coil domains 
were scored using the COILS program (Lupas et al., 1991).  All programs were 
accessed from by web interface on www.expasy.ch.  Protein-protein BLAST and pair-
wise BLAST ((Altschul et al., 1997; Altschul et al., 1990; Tatusova and Madden, 
1999) were performed using programs available on the National Centre for 
Biotechnology Information (NCBI) at www.ncbi.nlm.nih.gov.  All other sequence 
analysis presented here was performed by H. Lutz and M. Vingron (Max-Planck 
Institute for Molecular Genetics, Berlin). 
Plasmid constructions 
All cloning procedures were performed according to standard techniques as described 
in Molecular Cloning, A Laboratory Manual, 2nd editition, Sambrook, J.,Fritsch, E.F., 
Maniatis, T., Cold Spring Harbor Laboratory Press 1989 and Current Protocols in 
Molecular Biology, Wiley, 1999. Restriction enzyme reactions were carried out as 
specified by the suppliers (NEB) and ligation reactions were done using T4 DNA 
Ligase (NEB). Extraction of DNA from agarose gels and preparation of plasmid DNA 
was performed using kits from QIAGEN according to the manufacturer’s instructions. 
For PCR reactions, the Pfu DNA polymerase PCR System was used as recommended 
by the manufacturer (Promega) and reactions were carried out in a RoboCycler 
Gradient 96 (Stratagene). All PCR products were checked by sequencing at 
Medigenomix (Martinsried, Germany).   
The EST clone AI561146 IMAGE:2210962 encoding human Plk4 was purchased 
from RZPD, Berlin.  This clone was completely sequenced and found to contain the 
whole Plk4 coding sequence as well as portions of the 3′- and 5′-UTRs.  PCR was 
used to amplify full-length Plk4 and to introduce BamHI and XhoI sites either side of 
the coding sequence, respectively (for primers and cloning strategy, see Table 5).  The 
PCR product was phosphorylated with polynucleotide kinase (NEB, Frankfurt am 
Main, Germany) and blunt ligated into the SmaI site of the pBluescript II SK (-) 
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vector.  This construct (HR4) was sequenced and found to match the Plk4 reference 
sequence NM_014264 on Medline/NCBI, with the exception of a silent T→C point 
mutation at position 210 relative to the start codon.  To generate catalytically inactive 
Plk4, PCR used to introduce a point mutation in the conserved DFG motif of the 
kinase domain (Taylor et al., 1993b).  Mutation of the aspartate of this motif to 
alanine has been shown to completely abolish catalytic activity (Taylor et al., 1993a).  
This was achieved by altering codon 154 GAT (aspartate) to GCT (alanine) creating 
the HR22 plasmid (see Table 6 for a list of plasmids used in the work presented here).  
Similarly, a T-loop mutant was generated by altering codon 170 (ACA to GAT) 
thereby replacing the threonine with an aspartate residue.  All constructs were verified 
by sequencing.   
Deletion mutants (see Figure 23) of Plk4 were produced by PCR using internal 
primers and blunt-end ligating PCR products into pBluescript II SK(-).  Two deletion 
mutants (HR53 and HR54) were generated by virtue of a single EcoRV site present at 
the internal truncation point.  The EcoRV-XhoI fragment was excised from HR9 and 
the remaining DNA fragment containing the vector backbone and the truncated Plk4 
insert (residues 1-638) was blunt-ended and religated, thus generating the HR53 
plasmid.  Conversely, to generate HR54 containing the Plk4 C-terminus (residues 
638-970), the BamHI-EcoRV fragment was removed from HR4 and the vector blunt-
ended and religated.  cDNAs were then subcloned into the BamHI-XhoI sites of 
mammalian expression vectors generating wt and mutant Plk4 constructs with N-
terminal EGFP-, myc- or FLAG- tags.   
 
Yeast two-hybrid analysis 
The coding sequence of human K41R Plk4 was inserted into the two-hybrid prey 
vector pACT2 (Clontech Laboratories, Inc.) and the bait vector pFBT9 (a version of 
pGBT9 modified to encode kanamycin resistance; Clontech Laboratories, Inc.; a kind 
gift from F. Barr, Max-Planck-Institute for Biochemistry, Martinsried, Germany). 
These plasmids were cotransformed with into the yeast strain PJ69-4A to test for 
direct interactions.  Alternatively, a lymphocyte cDNA library (Clontech) was 
screened with bait constructs consisting of full length K41R Plk4 or a N-terminal 
mutant K41R Plk4 (residues 1-380).  Approximately 800,000 transformants were 
plated onto non-selective medium lacking either leucine and tryptophane (-WL) or on 
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selective medium lacking leucine, tryptophan and adenine with 2% (wt/vol) glucose 
as the carbon source (-WAL).  All results were confirmed by streaking colonies onto 
both selective and nonselective plates and scoring growth after 3-5 days at 30°C.   
Antibody Production 
A Plk4 fragment spanning residues 314-817 was expressed as a poly-histidine-tagged 
fusion protein in E. coli and purified over a Ni2+-column under denaturing conditions.  
350-500 µg of purified antigen was injected subcutaneously together with Freund’s 
adjuvant into New Zealand white rabbits every four weeks, to a total of six injections 
(animal house, Max-Planck Institute for Biochemistry, Martinsried, Germany).  
Antibodies were affinity purified by elution from immobilised antigen on 
nitrocellulose. 
 
Cell culture, transfections and microinjections.  
HeLa, U2OS, HEK293T or Cos-7 cells were cultured at 37°C in a 5% CO2 
atmosphere in Dulbecco’s modified Eagle’s medium (DMEM), supplemented with 
10% heat-inactivated fetal calf serum and penicillin-streptomycin (100 i.u./ml and 
100µg/ml, respectively, Gibco-BRL, Karlsruhe, Germany).  Cells adherent on acid 
treated glass coverslips were transiently transfected using FuGene (Roche 
Diagnostics, Mannheim, Germany) according to the manufacturer’s protocol.   
Tetracycline-inducible cell lines expressing FLAG-tagged wild type and D154A 
mutant Plk4 were generated by transfection of U2OS-TRex cells (Invitrogen) for 24 h 
prior to addition of selective reagent.  Stable transformants were established by 
selection for two weeks with 1mg/ml G418 (Invitrogen, Carlsbad, CA) and 50µg/ml 
hygromycin (Merck, Darmstadt, Germany) after which colonies were picked and 
tested for Plk4 expression by immunofluorescence and by Western blot analysis.  Cell 
lines were induced to express Plk4 by adding 1µg/ml tetracycline to growth medium. 
 
Centrosome duplication assays 
U2OS cells were seeded on acid treated, sterilised glass coverslips and transfected 
with either siRNA duplex oligonucleotides targeting Plk4 for 24 h or microinjected 
with anti-Plk4 antibodies.  Cells were then incubated for 64h in the presence of 2 mM 
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hydroxyurea or 1,6 µg/ml aphidicolin before fixation.  Centrosomes were stained 
using anti-γ-tubulin mouse monoclonal antibody (Sigma, Steinheim, Germany), and 
injected antibody was visualised by staining with Alexa green conjugated goat anti-
rabbit IgG secondary antibodies (Jackson Immunoresearch, Soham, UK).  Levels of 
Plk4 in cells transfected with siRNA duplex were monitored by staining with anti-
Plk4 antibodies.   
 
Antibody microinjections 
Antibody injections into U2OS cells were performed as previously described.  
(Blangy et al., 1995).  Briefly, U2OS cells were seeded onto acid treated coverslips 
and left to grow until 50-60% confluency for microinjection.  Purified anti-Plk4 
antibody or control rabbit IgG was concentrated to 2 mg/ml using Ultrafree-0.5 
centrifugal filters (Amicon Bioseparation, Millipore, Schwalbach, Germany), 
followed by centrifugation at 55,000 rpm for 30 minutes at 4°C in a TLA-55 rotor and 
an Optima ultracentrifuge (Beckman, Krefeld, Germany) prior to microinjection.  
Antibodies were injected into the cell cytoplasm using 0.5µm Femtotips glass needles 
with a micromanipulator 5171 coupled to a  FemtoJet/InjectMan microinjection 
apparatus (Eppendorf, Hamburg, Germany).  After microinjection, cells were used for 
centrosome duplication assays (see above).  
 
 
siRNA-mediated protein depletion. 
Plk4 protein was depleted using three different siRNA duplex oligonucleotides 
(Dharmacon Research Inc, Lafayette, CO and Qiagen, Hilden, Germany) targeting the 
sequences 5'-ACTCCTTTCAGACATATAAG-3' (oligo 1; 2913-2938, relative to start 
codon, in the 3’UTR), 5'-AACTATCTTGGAGCTTTATAA-3' (oligo 2; 212-232, 
relative to start codon) and 5'-CTGGTAGTACTAGTTCACCTA-3' (oligo 3; 2420-
2440, relative to start codon).  Duplexes were used singly or in combination (oligo 1 
plus 2), with similar results. For control, the luciferase duplex GL2 was used (Elbashir 
et al., 2001).  Transfections were performed using Oligofectamine (Life Technologies, 
Karlsruhe, Germany) according to standard protocols. 
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Flow cytometric analysis 
After transfection with siRNA duplexes, HeLa cells were detached by trypsinization 
and washed with ice-cold PBS. Cells were fixed in 70% ethanol, followed by an 
incubation for 30 minutes in PBS, 10µg/ml RNase A (Sigma-Aldrich) and 5µg/ml 
propidium iodide (Sigma-Aldrich). Analysis of the fixed cells was performed with a 
FACScan (Becton Dickinson) and the WinMDI software, according to the 
manufacturer’s instructions. 
 
Cell extracts, immunoprecipitations and immunoblotting 
For immunoprecipitations of epitope-tagged overexpressed proteins, HEK293T or 
Cos-7 cells were plated to approx. 50% confluency in 10cm cell culture dishes.  Cells 
were transfected as described above with 5µg of plasmid DNA using either FuGene 
(Roche Diagnostics, Mannheim, Germany) or by calcium phosphate precipitates as 
previously described elsewhere (Seelos, 1997).  For co-immunoprecipitations, 1.5µg 
of each plasmid encoding either bait and interactor were co-transfected.  24-48 h after 
transfection,  cells were washed three times with ice cold PBS and lysed on ice for 30 
min in extraction buffer for centrosomal proteins (0.1% IGPAL, 100mM KCl, 20mM 
Tris-HCl pH 7.4, 1mM DTT, 1mM EDTA, 10% glycerol, 50mM NaF, 5mM PMSF, 
Complete Mini protease inhibitor cocktail, Roche Diagnostics, Mannheim, Germany).  
Lysates were cleared by centrifuging for 8 min at 16,000xg, 4°C and incubated with 
prot-G beads bearing epitope-tag targeted antibodies (mouse monoclonal 9E10 anti-
myc; mouse M2 anti-FLAG affigel, Sigma, Steinheim, Germany; goat anti-GFP, a 
kind gift from F. A. Barr, Max-Planck Institute for Biochemistry, Martinsried, 
Germany) for 2h at 4°C.  Immunocomplexes bound to beads were then washed thrice 
with co-IP wash buffer (0.1% IGPAL, 250mM KCl, 20 mM Tris-HCl pH7.4, 1mM 
DTT, 1mM EDTA, 10% glycerol, 50mM NaF, 5mM PMSF).  Beads carrying bound 
proteins for use in kinase assays were treated as described below.  Otherwise, 
immunoprecipitated proteins were eluted into Laemmli buffer or, in the case of Flag-
tagged proteins, eluted with 0.5mg/ml of Flag peptide (Sigma, Steinheim, Germany) 
for 30 min at room temperature.  Eluates were separated by SDS-PAGE and 
transferred to nitrocellulose membranes using a Hoefer semi-dry blotting apparatus 
(Amersham Biosciences, Little Chalfont, UK) and completed transfer was assayed by 
staining membrane bound proteins with Ponceau-red.  For Western blot analysis, 
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membranes were incubated for one hour in blocking buffer (5% low-fat dry milk in 
PBS, 0.1% Tween-20). All antibody incubations were carried out in blocking buffer 
for 1 hour at room temperatur.   Membranes were probed with purified anti-Plk4, anti-
myc or anti-Flag antibodies in blocking buffer, followed by incubation with HRP 
conjugated goat anti-mouse or anti-rabbit antibodies (Jackson Immunoresearch).  
Signals were detected by enhanced chemiluminescence using ECL Supersignal 
reagents (Pierce Chemical Co.).   
 
Purification of the recombinant Plk4 (1-265) kinase domain  
The GST-tagged wt and catalytically inactive mutant of Plk4 (1-265) comprising the 
N-terminal catalytic domain was expressed in E. coli BRL RIL codon + (invitrogen).  
To express the protein, a starter culture of transformed bacteria was grown overnight 
under ampicillin selection and diluted to 1:5 with fresh medium in the morning.  The 
culture was grown until and OD600 of 1.0 when the expression of the recombinant 
protein was induced with 1mM IPTG at 30°C for 4h.  Cells were then pelleted by 
centrifugation, lysed in buffer (0.5% IGPAL, 100mM KCl, 20mM Tris-HCl pH7.4, 
1mM DTT, 1mM EDTA, 10% glycerol, 5mM PMSF) and centrifuged to remove 
debris.  Lysate was then incubated with glutathione coated beads (Amersham) for 1 
hour to allow binding of expressed protein.  After several washing steps with lysis 
buffer, GST-tagged Plk4(1-265) was then eluted by incubating beads in elution buffer 
(1mM glutathione, 20mM Tris-HCl pH7.4, 10 % glycerol, 1mM DTT).  Purified 
Plk4(1-265) was then frozen as aliquots at -80°C.   
 
In vitro kinase assays 
Following immunoprecipitation, tagged Plk4 immune complexes were washed three 
times with lysis buffer (0.1% IGPAL, 100mM KCl, 20mM Tris-HCl pH 7.4, 1mM 
DTT, 1mM EDTA, 10% glycerol, 50mM NaF, 5mM PMSF, Complete Mini protease 
inhibitor cocktail, Roche Diagnostics, Mannheim, Germany) and once with Plk4 
kinase buffer (50mM Hepes pH7.5, 10mM MgCl2, 1mM DTT).  Alternatively, 1 µg  
of recombinant  GST-tagged Plk4(1.265) kinase domain was used as enzyme.  Kinase 
reactions were carried out for 40min at  30°C in Plk4 kinase buffer supplemented with 
10µM ATP and 2µCi of [γ32-P]-ATP  (Amersham Corp.).  Kinase reactions were 
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stopped by addition of sample buffer and heating at  95°C for 5 minutes. Proteins 
were then separated by SDS-PAGE and transferred to nitrocellulose in the case of 
immunoprecipitated kinase or substrate.  Alternatively, when recombinant proteins 
were used proteins were stained by Coomassie Blue followed by drying on filter 
paper.  32P incorporation was visualized by autoradiography. 
 
Microscopic techniques. 
Immunofluorescence microscopy was carried out as described (Meraldi et al., 1999a). 
Briefly, cells were fixed on coverslips in -20°C methanol for at least 5 minutes before 
incubation in blocking buffer (1% BSA in PBS).  After rehydration in PBS, cells were 
incubated with primary antibodies in blocking buffer for 1 hour at room temperature, 
followed by staining with Alexa-Fluor conjugated goat secondary antibodies 
(Molecular probes).  DNA was visualised by staining with DAPI (200 ng/ml).  
Coverslips were mounted onto glass slides using mounting medium 
(phenylenediamine in 90% glycerol).  Slides were analyzed using a Zeiss Axioplan II 
microscope with Apochromat  63x and 100x/1.4 n.a. oil immersion objectives and 
images were taken using a CoolSNAP HQ CCD camera (Photometrics, Tuczon, AZ) 
and Metaview (Visitron Systems GmbH, Puchheim, Germany) software followed by 
processing with Adobe Photoshop (Adobe Systems, Mountain View, CA). 
Alternatively, slides were analyzed using a Deltavision microscope on a Nikon TE200 
base (Applied Precision, Issaquah, WA) equipped with an APOPLAN 60x/1.4 n.a. oil 
immersion objective.  Serial optical sections obtained 0.2 µm apart along the Z-axis 
were processed with a deconvolution algorithm and projected into one picture using 
Softworx (Applied Precision).  
 
Electron microscopy and immunogold labelling 
Electron microscopy was kindly performed by Y-D Stierhof (ZMBP, University of 
Tübingen, Germany).  For electron microscopy, cells were induced for 48 h to express 
wt or D154A Plk4, fixed with 2.5% glutaraldehyde (Sigma-Aldrich, Steinheim, 
Germany) in PBS for 60 min, embedded in 2% low melting agarose (SeaPlaque 
Agarose; Marine Colloids, Rockland, USA) and post-fixed with 1% osmium tetroxide 
(Plano, Wetzlar, Germany) in PBS for another 60 min followed by staining with 1 % 
uranyl acetate (Science Services, München, Germany) in distilled water for 45 min. 
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After dehydration with ethanol, cells were embedded for ultrathin sectioning in epoxy 
resin (Epon; Roth, Karlsruhe, Germany). Sections were stained with 1% uranyl 
acetate and lead citrate (Science Services, München, Germany) and viewed in a LEO 
906 transmission electron microscope. 
Immunogold labelling 
 
Mass-spectrometry 
Proteins isolated by co-immunoprecipitation with FLAG-tagged wt Plk4 were kindly 
analysed by X. Li (Max-Planck Institute of Biochemistry, Martinsried, Germany) as 
previously described (Sauer et al., 2005).  Briefly, Coomassie Blue stained protein 
bands were in-gel digested (Shevchenko et al., 1996) by trypsin (Promega, sequencing 
grade).  Peptides were desalted and concentrated using C18 extraction tips, and 
analysed with a CAPLC nano HPLC system (Waters, Milford) coupled to a Q-TOF 
mass spectrometer (Q-ToF, Ultima, Micromass, London, UK).  Data were searched 
against the Mass Spectrometry Protein Sequence Database (MSDB, csc-
fserve.hh.med.ic.ac.uk/msdb.html) or the human International Protein Index database 
(www.ebi.ac.uk/IPI/IPIhelp.html) using in-house Mascot version 1.7 
(www.matrixscience.com).  Proteins identified by two or more peptides with a 
combined peptide score higher than 50 or by one single peptide with a score higher 
than 60 were considered significant, whereas all lower-scoring proteins were either 
included or discarded after inspection of individual spectra.    
 
Miscellaneous techniques 
Human centrosomes were purified from the T-lymphocyte KE-37 cell line according 
to the protocol reported in (Moudjou and Bornens, 1994).  MT regrowth assays in 
asynchronously growing U2OS cells were performed by placing tissue culture plates 
on ice for 30 mins, before MT regrowth was induced by the addition of prewarmed 
growth medium for 30s.  Cells were then immediately fixed in -20° methanol and 
prepared for immunofluorescence.  Cdk2 was inhibited in aphidicolin treated cells by 
adding Roscovitin to growth medium at a final concentration of 25µM.   
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ABBREVIATIONS 
All units are abbreviated according to the International Unit System. 
AA: amino acid(s) 
ATP: adenosine 5´-triphosphate 
BSA: bovine serum albumin 
DAPI: 4´,6-diamidino-2-phenylindole 
DTT: dithiothreitol 
ECL: enhanced chemiluminescence 
EDTA: ethylenedinitrilotetraacetic acid 
EGFP: enhanced green fluorescent protein 
EM: electron microscopy 
FCS: Fetal calf serum 
GFP: green fluorescent protein 
HCl: hydrochloric acid 
HEPES: N-2-Hydroxyethylpiperazine-N`-2-ethane sulfonic acid 
IgG:  Immunoglobulin G 
IP:  Immunoprecipitation 
IPTG: isopropyl-beta-D-thiogalactopyranoside 
mAb: monoclonal antibody 
MTOC: microtubule organising centre 
PBS: Phosphate-buffered saline 
PCR: Polymerase chain reaction 
Plk4: Polo-like kinase 4 
PMSF: phenylmethylsulfonyl fluoride 
RNA: Ribonucleic Acid 
RT: room temperature 
SAK: Snk/Fnk akin kinase 
SDS-PAGE: Sodium dodecylsulfate polyacrylamid gelelectrophoresis 
siRNA: small interference Ribonucleic Acid 
SPB: Spindle Pole Body 
WT: wild-type 
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Table 5 List of primers used to introduce point mutations in Plk4 
 
Primer name Sequence (5´-3´) mutation 
introduced 
M1251 oHR033 GGAAGTTGCAATCCGGATGATAGATAA K41R 
M1252 oHR034 CTTATCTATCATCCGGATTGCAACTTCC K41R 
M1575 oHR039 CATCAAGATTGCTGCTTTTGGGCTGGCA
AC 
D154A 
M1581 oHR042 GTTGCCAGCCCAAAAGCAGCAATCTTG
ATG 
D154A 
M1575 oHR041 CATGAAAAGCACTATGACTTATGTGGA
ACTCC 
T170D 
M1583 oHR044 GGAGTTCCACATAAGTCATAGTGCTTTT
CATG 
T170D 
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Table 6 List of plasmids. Epitope tags are N-terminal unless otherwise stated.  Several plasmids used 
were generated by other people, in particular P. Meraldi (PM), L. Arnaud (LA) and J. Kleylein-Sohn 
(JK).   
 
Name  Gene Species Insert Vector tag 
HR9 Plk4 Human full length; wt pcDNA3.1-3xmycA myc 
HR57 Plk4 Human full length; wt pcDNA3.1-NFLAG flag 
HR38 Plk4 Human full length; wt pEGFP-C2 N-terminal 
EGFP 
HR44 Plk4 Human full length; wt pEGFP-N3 C-terminal  
EGFP 
HR26 
 
Plk4 Human full length; D154A 
mutation 
pcDNA3.1-3xmycA myc 
HR63 Plk4 Human full length; T170D 
mutation 
pcDNA3.1-3xmycA myc 
HR46 Plk4 Human full length; K41R pFBT9 DNA binding 
domain 
HR17 Plk4 Human Full length; K41R pACT2 activation 
domain 
HR105 Plk4 Human aa 1-380; K41R pACT2 activation 
domain 
HR57 Plk4 Human aa 1-888; wt pcDNA3.1-3xmycA myc 
HR53 Plk4 Human aa 1-638; wt pcDNA3.1-3xmycA myc 
HR55 Plk4 Human aa 888-970 pcDNA3.1-3xmycA myc 
HR54 Plk4 Human aa 638-970 pcDNA3.1-3xmycA myc 
HR56 Plk4 Human aa 265-970 pcDNA3.1-3xmycA myc 
HR87 Plk4 Human aa 1-265; wt pGEX-5X-2 GST 
HR88 Plk4 Human aa 1-265; D154A pGEX-5X-2 GST 
JK CPAP Human full length pEGFP-C2 EGFP 
JK CPAP Human aa 1-132 pEGFP-C2 EGFP 
JK CPAP Human aa 1-422 pEGFP-C2 EGFP 
P. Gönczy CPAP  Human aa 429-890 pEGFP-C1 EGFP 
PM22 p27 Human full length pRcCMV myc 
LA178 Cdk2 Human dominant negative pRSC-EGFP EGFP 
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